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ABSTRACT 
 
 
 
 
Background and objectives : Adjuvants to local anaesthetics  for brachial 
plexus  block  enhances the quality and duration of analgesia. Midazolam , 
a water-soluble benzodiazepine, is known to produce antinociception  and 
enhance the effect of local anaesthetics when given epidurally or 
intrathecally. The purpose of this study was to assess the effect of 
Midazolam added to brachial plexus block by supraclavicular approach. 
 
 
Methods : A prospective, randomized, single blinded study was conducted 
on 100 ASA I or II adult patients undergoing upper limb surgeries under 
supraclavicular  brachial plexus block. Patients were randomly divided into 
two groups. Patients in Group B (n = 50) were administered 30mL of 
0.375% Bupivacaine and Group BM (n = 50) were given 30mL of 0.375% 
Bupivacaine with Midazolam 2.5 mg. The onset time and duration of 
sensory and motor blockade were recorded. Hemodynamic variables 
(i.e., heart rate, noninvasive blood pressure, oxygen saturation), sedation 
scores and rescue analgesic requirements were recorded for 24 hr 
postoperatively. 
 
                                           
 
 Results : The onset of sensory and motor block was significantly faster in 
Group BM compared to Group B (P < 0.05). Rescue analgesic requirements 
were significantly less in Group BM compared to Group B (P < 0.05). 
Haemodynamics and sedation scores did not differ between the two groups    
in the post-operative period. 
 
 
Conclusion : Midazolam (2.5mg) in combination with 30mL of 
Bupivacaine (0.375%) hastened onset of sensory and motor block, and 
prolonged postoperative analgesia when used in brachial plexus block, without 
producing any adverse effects. 
 
 
 
Keywords : Supraclavicular brachial plexus block; Midazolam; Bupivacaine. 
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INTRODUCTION 
 
 
“ Pain, like pleasure is passion of the soul, 
That is an emotion and not one of the senses” 
- PLATO and ARISTOTLE (375 B.C) 
Pain is a fundamental biological phenomenon. The International Association 
for the Study of pain has defined “pain as an unpleasant sensory and emotional 
experience associated with actual or potential  tissue damage." Pain is always 
under estimated and under treated. The relief of pain during surgery is the main 
part of anaesthesia. 
 
Regional nerve blocks provide unwanted side effects of anaesthetic drugs 
used during general anaesthesia and the stress of laryngoscopy and tracheal 
intubation .It provides better intraoperative and prolonged pain relief during 
postoperative period. Minimising the stress response and minimising anaesthetic 
drug requirements are beneficial to the patients with various cardiorespiratory 
comorbidities. 
 
      Brachial plexus blocks provide a wonderful alternative to general anaesthesia  
for upper limb surgeries. They achieve near-ideal operative conditions by 
providing complete and prolonged pain relief, muscle relaxation, maintaining   
stable   intra-operative   hemodynamics and  adequate sympathetic block. The 
sympathetic block decreases postoperative pain, vasospasm and edema.1 
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         Of various local anaesthetics, Bupivacaine is used most frequently, as it has 
a long duration of action varying from 3 to 8 hours. However there are many 
limiting  factors like delayed onset, patchy or incomplete analgesia, sometimes of  
short duration etc. Various drugs like Dexmedetomidine, 
Opioids2,Hyaluronidase3, Clonidine etc4.have been added to local anaesthetics in 
order to  modify the block in terms  of quicker onset, good quality, prolonged 
duration and post operative analgesia. But these presented with adverse 
systemic  effects or doubtful  efficacy.4 
 
    Midazolam, a water-soluble benzodiazepine is known to produce 
antinociception and  enhance the effect of local anaesthetic when given 
epidurally or intrathecally5. Midazolam produces this effect by its action on 
gamma aminobutyric acid-A (GABA-A) receptors. GABA receptors have also 
been found in peripheral nerves
5
. 
 
So the present study is being undertaken in a randomized s i n g l e   
blinded manner to evaluate the onset time and analgesic efficacy of 
Midazolam(preservative free)- Bupivacaine combination compared to plain 
Bupivacaine(0.375%) for brachial plexus block by  supraclavicular approach. 
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              Aim of the study   
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AIM OF THE STUDY 
 
 
 
 
     The present study was undertaken to compare the efficacy of  
 
      adding  midazolam (2.5mg) to bupivacaine (0.375%) in supraclavicular   
 
technique of brachial plexus block for upper limb surgeries with respect to       
 
           1) Onset time and duration of sensory and motor blockade. 
 
  
2) Hemodynamic changes 
 
  
3) Sedation score intra and post-operatively 
 
  
4) Number of rescue analgesics required in the 24 hour post-operative 
period. 
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  Brachial Plexus Block 
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HISTORY 
 
1. 1858 – theory of pain was a separate and distinct sense was definitely 
formulated by Mortiz S.Schiff 
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8.  Melzock and Walts (1965) propounded the Gate Control Theory of pain. 
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ANATOMY OF BRACHIAL PLEXUS 6,7 
   
Knowledge of formation of brachial plexus and its ultimate 
cutaneous and muscular distribution is absolutely essential to the 
intelligent and effective use of  brachial plexus anaesthesia for upper 
limb surgeries. Close familiarity with the vascular, muscular and fascial 
relationships of the plexus is equally essential to the mastery of various 
techniques ,  for it is these  perineural structures which serve as the  
landmark by which needle may accurately locate the plexus percutaneously. 
         In its course from intervertebral foramina to the upper arm, the fibres are 
  
  composed consecutively of roots, trunks, divisions, cords and terminal    
nerves. 
 
        FORMATION OF BRACHIAL PLEXUS : 
  
Brachial plexus is formed by the union of ventral rami of lower four 
cervical nerves (C5, 6,7,8) and first thoracic nerve (T1) with frequent 
contributions from C4 or T2.When contribution from C4 is large and from 
T2 is lacking, the plexus appears to have a more cephaloid position and is 
termed “Prefixed”. When contribution from T2 is large and from C4 is 
lacking, the plexus appears to have a caudal position and is termed 
“postfixed”. Usually prefixed or postfixed positions are associated with 
the  presence either of a cervical rib or of an anomalous first rib.6 
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ROOTS : 
  Represent the anterior primary divisions of lower four cervical 
and first thoracic nerves. They emerge from the intervertebral foramina and 
fuse above the first rib to form the trunks. 
 
TRUNKS : 
        The roots combine above the first rib to form the three trunks of the 
plexus. C5 and C6 unite at the lateral border of the scalenus medius and 
form the “Upper trunk”.C8 and T1 unite behind the scalenus anterior to 
form “lower trunk” and C7 continues as a sole contributor to the “middle 
trunk”. 
 
DIVISIONS : 
         As the trunks pass over the first rib and under the clavicle, each one 
of them divides into anterior and posterior divisions. 
 
   CORDS : 
The fibres, as they emerge from under the clavicle, recombine to 
form three cords. The “lateral cord” is formed by anterior divisions of 
upper and middle trunks, lateral to the axillary artery. The anterior division 
of lower trunk descend medial to the axillary artery forming the “medial 
cord”. The posterior divisions of all three trunks unite to form the 
10 
 
“posterior cord”, at first above and then behind the axillary artery. The 
medial and lateral cords give rise to nerves that supply the flexor surface of 
upper extremity, while nerves arising from posterior cord supply extensors7 
 
MAJOR TERMINAL NERVES : 
 
  
    Each of these cords gives off a branch that contributes to or become 
one of the major nerves to the upper extremity and then terminates as a 
major nerve. The lateral and median cords give off lateral and medial 
heads of the medial nerve and continue as major terminal nerves, the 
lateral cord terminating as musculocutaneous nerve and medial cord as 
ulnar nerve. Posterior cord gives off, axillary nerve as its major branch and 
then continues as the radial nerve. 
 
 
                                                         
DISTRIBUTION OF BRACHIAL PLEXUS : 
 
 
  
       These are divided into those that arise above the clavicle – the 
supraclavicular branches and those that arise below it, the infraclavicular 
branches. 
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       Supraclavicular branches : 
  
From roots : 
  
1. Nerves to scaleni and longus colli – C5,6,7,8 
  
2. Branch to phrenic nerve – C5 
  
3. Dorsal scapular nerve – C5 
  
4. Long thoracic nerve – C5,6,(7) 
  
From trunks : 
  
1. Nerve to subclavius – C5,6 
  
2. suprascapular nerve – C5,6, 
 
  
 
Infraclavicular branches : They branch from cords but their fibres may be 
tracked back to spinal nerves. 
 
Lateral cord : 
  
1. Lateral pectoral nerve – C5,6,7 
  
2. Musculocutaneous nerve – C5,6,7 
  
3. Lateral root of median nerve – C5,6,7 
 
  
Medial cord : 
  
1. Medial pectoral nerve – C8, T1 
  
2. Medial cutaneous nerve of forearm – C8, T1 
  
3. Ulnar nerve – C8, T1 
  
4. Medial root of median nerve – C8, T1 
  
5. Medial cutaneous nerve of arm – C8, T1 
12 
 
  
Posterior cord : 
  
1. Upper subscapular nerve – C5, 6 
  
2. Thoracodorsal nerve – C 6, 7, 8 
  
3. Lower subscapular nerve – C5, 6 
  
4. Axillary nerve – C5, 6 
  
5. Radial nerve - – C5, 6, 7, 8, T1 
 
 
 
SYMPATHETIC CONTRIBUTION TO BRACHIAL PLEXUS : 
 
  
The segmental preganglionic sympathetic contributions are   
variable, but generally extend more caudal. The highest contribution is 
usually T2 with T1 contributing only rarely, while lowest may be as far as 
T8, T9 or even T10. The post ganglionic contributions are from grey rami 
communicants from the sympathetic chain. 
 
 
RELATIONS OF BRACHIAL PLEXUS  :8 
 
  
       In its passage from the cervical transverse processes to the first rib, the 
plexus is "sandwiched" between the anterior and middle scalene muscles and 
invested in the fascia of those two muscles. The 'interfascial compartment', 
along  with subclavian artery which crosses the first rib immediately in front of 
the trunks. Artery is close to the scalenus anterior and the plexus close to the 
scalenus medius. Subclavian vein is separated from the artery by the 
13 
 
scalenus anterior. The fascia covering the muscles is derived from the 
 perivertebral fascia, which splits to invest these muscles and rejoins again           
at their lateral margins to form an enclosed space, the interscalene space. 
                    
      As the plexus crosses the first rib, the three trunks are 'stacked' one on 
top of the other vertically. Not infrequently, the inferior trunk gets trapped 
behind and even beneath the subclavian artery above the rib, during 
embryologic development. This may be reason why local anaesthetics 
injected via the interscalene technique sometimes fail to provide anaesthesia 
in the distribution of the ulnar nerve, which may be buried deep within 
inferior trunk behind or beneath the subclavian artery. 
            
        After crossing the first rib, they split to form 2 divisions and the 
cords and subclavian artery becomes the axillary artery. Above the clavicle, 
the axillary artery lies central to the three cords, in the axilla the lateral and 
posterior cords are lateral to the first part of the axillary artery, the medial cord 
being behind it. Around the second part of the artery, they are related 
according to their names. In the lower axilla, cords divide into nerves for the 
upper limb. In passing over the first rib under the clavicle, the subclavian 
vein also becomes the axillary vein and its relationship with the 
neurovascular bundle changes. Above the first rib the subclavian vein does 
not lie within  the neurovascular bundle, it is separated by the insertion of 
14 
 
scalenus anterior.  
                        As it passes over the first rib, becoming the axillary vein it 
joins the neurovascular bundle so that parts of the plexus are sandwiched 
between artery and vein. As all the three enter the axilla, they invaginate the 
perivertebral fascia at the lateral margins of the anterior and medial scalene 
muscles, carrying this fascial investment of the neurovascular bundle into 
the axilla as the axillary fascia, an extension of the perivertebral or 
scalene fascia forming the axillary perivascular space, a tubular 
       extension of the interscalene space. 
                                     
                                                       
                                 
                  In its course through the axilla and upper arm the fascia of the 
surrounding muscles contribute to the axillary sheath, making it thick and 
tough, providing the 'fascial click' to the anaesthetic while entering the 
sheath. It is important to note that major  terminal nerves leave the sheath 
high in the axilla undercover of perctoralis minor muscle. 
 
                 The musculocutaneous nerve enters the substance of 
coracobrachialis and continues down within this muscle. The axillary 
nerve also leaves the sheath immediately after arising from the posterior 
cord. The intercostobrachial nerve travels parallel to but outside the axillary 
sheath and medial cutaneous nerve of the arm runs similarly but occasionally 
it may remain within the sheath. 
15 
 
 
 
      THE BRACHIAL PLEXUS SHEATH 
 
 
       Volume of the sheath : 42ml. 
  
Shape of the sheath : Cylindrical to conical – Wide proximally and narrow  
 
distally. 
  
Length : 8-10cms long. 
 
  
       The connective tissue of the prevertebral fascia and the anterior and   
 
    middle scalenes envelops the brachial plexus as well as the subclavian and  
 
  axillary artery in a neurovascular “sheath”.The tissue is densely organized as 
it leaves the deep cervical fascia proximally but becomes more loosely 
arranged distally. The sheath blends with the fascia of the biceps and 
brachialis muscle distally. 
 
 
          Anatomic dissection, histologic examination and CT scanning after 
injection of radio contrast into the sheath demonstrate the existence of 
connective tissue septae which extend inward from the fascia 
surrounding the sheath. The thin velamentous connective tissue septae 
frequently adhere to t h e  nerves and vessels leaving no free space between 
the  layers and compartmentalizing the components of the sheath. 
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   Anaesthetic Implications : 
  
   Because of these connective tissue septae, anaesthesia might be complete and 
rapid in onset in some nerves, but delayed and incomplete or completely absent 
in others. The incidence of partial block is an exception rather than the rule, so 
septa apparently are of little clinical significance as the local anaesthetic can 
percolate through them. 
 
 
 
 
 
 
TECHNIQUE OF BRACHIAL PLEXUS BLOCK9 
 Surgical anaesthesia of the upper extremity and shoulder can be obtained 
following neural blockade of the brachial plexus at several sites. The various  
approaches that can be used for this blockade are as follows 
1.Interscalene approach 
2. Supraclavicular approach 
a. Classic approach 
b. Plumb –bob technique 
c. Subclavian perivascular technique 
3. Axillary approach 
4. Infraclavicular approach 
  
17 
 
Supraclavicular approach 10 
a. Classic approach 
Patient Position:  Supine, with the head turned to the opposite side and 
the arm adducted and the shoulder dropped.  
 
Indications:  Anesthesia and immediate postoperative analgesia for 
surgery above the elbow, or at the elbow, forearm, wrist, or hand.  
 
Needle Size:  22-gauge , 5-cm insulated needle. 
 
Volume: 30 to 40 mL. 
 
Anatomic Landmarks:  The lateral border of the clavicular head of the 
sternocleidomastoid at its insertion into the clavicle, the subclavian 
artery, and the anterior and middle scalene muscles.  
 
Approach and Technique: First, the lateral border of the 
sternocleidomastoid, particularly at the level of its insertion into the 
clavicle, is marked. Next, the interscalene groove is identified and 
marked. The palpating finger is placed parallel and immediately 
superior to the clavicle at the level of the subclavian artery and the 
interscalene groove. The insulated needle, connected to a nerve 
18 
 
stimulator (1.0 mA, 2 Hz, 0.1 ms) is inserted posterior to the palpating 
finger (Fig. 4). The needle is directed caudad and lateral, so as to cross 
the clavicle almost perpendicularly. A muscle response involving the 
arm and fingers either in flexion or extension is elicited within 2 to 3 
cm. The position of the needle is adjusted to maintain the same motor 
response with a current of 0.5 to 0.7 mA. After negative aspiration for 
blood, the local anesthetic is slowly injected with repeated aspiration 
for blood every 5 mL to be distributed around the brachial plexus  
 
B) Plumb bob approach10 
 
Patient Position: Supine, with the head turned to the opposite side and 
the arm adducted and the shoulder dropped.  
 
Approach and Technique  Patient’s head is slightly off the back table 
so that lateral border of sternocleidomastoid is marked as it inserts to 
the clavicle.From that point,a mental plane is visualised that runs parasagittaly 
through that site. “Plumb blob” was chosen,since if one suspends a “plumb-
blob”over the entry site,needle insertion through the point will result in contact 
with brachial plexus  mostly.Brachial plexus lies posterior and cephalad to 
subclavian artery at the level of first rib.Once the skin mark has been 
placed,immediately superior to the clavicle at the lateral border of 
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sternocleidomastoid ,needle is inserted in parasagittal plane at 90
0 
angle to the table 
top.Once paraesthesia has been elicited, after negative aspiration for blood, 
the local anesthetic is slowly injected with repeated aspiration for 
blood every 5 mL to be distributed around the brachial plexus .  
 
LOCAL ANESTHETIC MECHANISMS IN NERVE BLOCKADE11 
Impulse blockade by local anesthetics may be summarized by the following 
chronolog: 
• Solutions of local anesthetic are deposited near the nerve. Removal of free 
drug molecules away from this locus is a function of tissue binding, removal 
by the circulation, and local hydrolysis of amino-ester  anaesthetics. The net 
result is penetration of the nerve sheath by the remaining free drug molecules. 
• Local anesthetic molecules then permeate the nerve‘s axon membranes and 
reside there and in the axoplasm. The speed and extent of  these  processes 
depend on a particular drug‘s pĸa and on the lipophilicity of its base and cation 
species. 
• Binding of local anesthetic to sites on voltage-gated Na+ channels prevents 
opening of the channels by inhibiting the conformational changes that underlie 
channel activation. Local anesthetics bind in the channel’s pore and also 
occlude the path of Na+ ions. 
20 
 
• During onset or recovery from local anesthesia, impulse blockade is incomplete 
and partially blocked fibres are further inhibited by repetitive stimulation, which 
produces an additional use-dependent blinding to Na+ channels. 
• One local anesthetic binding site on the Na+ channel may be sufficient to account 
for the drug's resting (tonic) and use-dependent (phasic) actions Access to this site 
may potentially involve multiple pathways, but for clinical local anesthetics, the 
primary route is the hydrophobic approach from within the axon membrane. 
• The clinically observed rates of onset and recovery from blockade are governed 
by the relatively slow diffusion of local anesthetic molecule into and out of the 
whole nerve, not by their much faster binding and dissociation from ion channels. 
A clinically effective block that may last for hours can be accomplished with local 
anesthetic drugs that dissociate from Na+ channels in a few seconds11.  
 
 
COMPLICATIONS12 
Vascular puncture 
Internal jugular vein may be punctured at skin wheal infiltration. Simple digital 
compression is required before continuing, the likelihood of  arterial  puncture 
implies not to pinpoint  behind and too  medial  from  midclavicle.  Best is to 
withdraw and redirect the needle when perceiving artery pulsation at the needle 
tip. 
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Pleural puncture 
The most significant complication of supraclavicular approach for blocking 
brachial plexus is development of pneumothorax. The incidence of pneumothorax 
is 1 percent with this technique and much higher in inexperienced hands.A 
pneumothorax must be suspected when there is dyspnoea, cough or pleuritic chest 
pain but the diagnosis can be confirmed only by chest x-ray. 
 
Phrenic nerve block 
Phrenic nerve block  occurs in 40-60% of patients  because  of spread of local 
anaesthetic to the anterior surface of anterior scalene muscle. The effect is avoided 
if anaesthetic is deposited deep on the middle trunk on division or cord. This is 
rarely symptomatic. Radiographic confirmation may be obtained. 
 
Recurrent laryngeal nerve block 
It causes transient dysphonia, occurs in 1% of case and only on the right side 
because recurrent laryngeal nerve loops around the subclavian artery on the right 
side and arch of aorta on the left. 
 
Nerve damage or neuritis 
It results from the needle trauma or faulty positioning of anaesthetised arm 
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preoperatively. Other remote causes include excessive tourniquet time, 
concentrated solution with vasoconstrictor and susceptible host tissue. 
 
Horner's syndrome 
It consists of ptosis, miosis, anhydrosis and enophthalmos. It usually follows 
stellate ganglion block. It is found in 10% of cases, after interscalene block. 
 
Toxic reaction to drug 
It is likely to occur if there is over dosage of drug or inadventent intravascular 
injection is made, but can be avoided with proper negative aspiration test before 
drug injection 
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     PHARMACOLOGY OF MIDAZOLAM13,14,15,16 
 
  
         Midazolam is a water soluble benzodiazepine. It was first synthesized 
by Fryer and Walser in 1976. It was the first benzodiazepine that was 
produced primarily for use in anaesthesia.It is associated with a low 
incidence of injection pain and post injection phlebitis and thrombosis. It has 
replaced diazepam as the most commonly administered benzodiazepine in 
the perioperative period for preoperative medication and intravenous 
“conscious” sedation. The five principal pharmacologic effects are: 
sedation, anxiolysis, anticonvulsant actions, spinal cord-mediated skeletal 
muscle relaxation and anterograde amnesia. 
 
 
 
Chemistry : 
 
  
     The molecular weight is 362 with a pKa of 6.2. The parenteral 
solution used clinically, is buffered to an acidic pH of 3.5. This is important 
because Midazolam  exhibits a pH dependent ring opening phenomenon in 
which the ring remains open at pH values of less than 4, thus maintaining 
water solubility of the drug.This water solubility results in a low incidence of 
injection pain and venous thrombosis.  The ring closes at pH values of more 
than 4, as when the drug is exposed to physiologic pH, thus converting 
Midazolam to a highly lipid soluble drug.Midazolam is the most lipid soluble 
benzodiazepine currently available. 
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 Chemical structure :
 
 
             Midazolam has a fused imidazole ring that is different from 
classic benzodiazepines. The imidazole ring accounts for the basicity, 
stability of an aqueous solution and rapid metabolism. It is named 8-
chloro-6(2-flurophenyl)-1-methyl-4H- imidazo-(1, 5-) (1, 4) benzodiazepine 
maleate. Reversible ring opening of midazolam above and below a pH of 4; 
the ring closes at a pH> 4, converting  midazolam from a water soluble to a 
lipid soluble drug. 
 
pH DEPENDENT RING OPENING OF MIDAZOLAM 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 Fig. 7  : Reversible ring opening of Midazolam above and 
below a pH of 4; the ring closes at a pH> 4, converting 
Midazolam from a water soluble to a lipid soluble drug. 
 
a. The active lipid soluble ring configuration in blood. 
 
b. The inactive water soluble configuration open ring. 
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      Mechanism of action : 
  
Midazolam and benzodiazepines in general appear to produce 
all their pharmacologic effects by facilitating the actions of gamma 
amino butyric acid  (GABA), the principal inhibitory neurotransmitter in 
the CNS. GABA-adrenergic neurotransmission counterbalances the 
influence of excitatory neurotransmitters. The benzodiazepine receptors are 
found in highest densities in the olfactory bulb, cerebral cortex, cerebellum, 
hippocampus,  substantia nigra  and inferior colliculus. Current data suggests 
a pentameric protein composed of , , and subunits; the proposed 
arrangement of subunits is arbitrary. (Fig. 8 A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8A : Schematic model of the GABAA receptor 
complex illustrating recognition sites for many of the 
substances that bind to the receptor. 
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       The GABA type A (GABAA) is a receptor complex consisting of up 
to five glycoprotein subunits. When the GABAA     receptor is 
activated, transmembrane chloride conductance increases, resulting in 
hyperpolarization of the postsynaptic cell membrane and functional 
inhibition of the postsynaptic neuron. Midazolam binds to a specific 
receptor site that is a part of the GABAA receptor complex. The 
binding increases the efficiency of the coupling between the GABA 
receptor and the chloride ion channel. (Fig. 8 B) 
 
 
 
BNZ FACILITATES INHIBITORY ACTIONS OF GABA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BNZ MIMICS INHIBITORY ACTIONS OF GLYCINE 
 
 
Fig. 8B: Mechanisms and sites of action of benzodiazepines 
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Pharmacokinetics : 
 
 
 
Midazolam blood levels decrease rapidly because of its high hepatic 
clearance, relatively shorter elimination half life (t1/2 ) and rapid 
redistribution from the brain to inactive tissue sites. The termination of action 
after single doses is caused both by distribution into peripheral tissues and by 
metabolic biotransformation. The context- sensitive half time is shorter when 
compared to other benzodiazepines with a slow effect-site equilibrium time. 
It undergoes extensive hydroxylation by hepatic microsomal oxidative 
mechanisms and the water soluble metabolites are excreted in urine as 
glucoronide conjugates. Less than 0.5% is excreted unchanged in the urine. 
      First pass metabolism is high. Clearance is also sensitive to hepatic blood flow. 
 
 
 
 
 
    Table A : Pharmacokinetics of Midazolam 
 
  
Distribution half life (t½ ) 
 
7 – 15 minutes 
 
Elimination half life (t½ ) 
 
1.7 – 2.6 hours 
 
Protein binding 
 
94% 
 
Clearance 
 
6.4 – 11 ml.kg-1. min-1 
 
Distribution volume at steady state (Vdss) 
 
1.1 – 1.7 L/kg 
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        Metabolism : 
 
  
               Midazolam undergoes extensive hydroxylation by hepatic 
microsomaloxidative mechanisms (cytochrome p-4503A4, p4503A3 and 
p4503A5) to form - hydroxymidazolam, the principal metabolite 
and  small  amounts of 4-hydroxymidazolam and even smaller amounts of 
4-dihydroxymidazolam (Fig. 4).These water soluble metabolites are 
excreted in urine as glucoronide conjugates.Very little (< 0.5%) 
unchanged midazolam is excreted by the kidneys. Plasma concentrations 
accumulate over the first 30 minutes after administration and reach the highest 
concentration in the first 2 hours. 
  
 
Excretion : 
 
  
Less than 1% of midazolam is excreted unchanged by the kidney.  
       The metabolities are conjugated with glucoronic acid and all are excreted as 
glucoronides.The principal excretory product is the -
hydroxymethylmidazolam glucoronides. 
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Fig. 9 : Metabolism of Midazolam, with -hydroxy 
midazolam occurring in the greatest quantity. All the 
hydroxylated metabolites are quickly excreted via the 
kidneys. 
 
 
      Pharmacodynamics : 
 
 
 
Increasing plasma concentrations correlate with clinical effects. 
Assessment of effects are carried out progressively as a steady state is 
achieved. The half life of equilibrium between plasma concentration of 
midazolam and its maximal EEG effect is only 2-3 minutes, the time within 
which sedation is apparent. The therapeutic window to maintain 
unconsciousness with midazolam is reported to be 100-200 ng/ml with 
awakening occurring at plasma concentration below 50 ng/ml. 
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      Effects on organ systems : 
 
  
Central nervous system : Midazolam like other benzodiazepines is a 
sedative-hypnotic and anxiolytic. It has been suggested that a BZD receptor 
occupancy of 20% provides anxiolysis, while 30-50% receptor occupancy is 
associated with sedation and greater than 60% receptor occupancy is required 
for hypnosis (unconsciousness).It decreases in a dose related manner both 
cerebral metabolic rate for oxygen(CMRO2) and cerebral blood flow (CBF) 
maintaining a relatively normal ratio of CBF to CMRO2. In patients with 
intracranial pathology, it decreases cerebral perfusion pressure (CPP) with little 
effect on intracranial pressure (ICP). It is also a potent 
anticonvulsant.Midazolam when administered orally, causes anterograde 
amnesia. Anterograde amnesia generally persists for 20-40 minutes after IV 
injection of a single dose. The ability to produce a short period of 
anterograde amnesia is a useful feature of the efficacy of midazolam when 
used as a sedative for endoscopy and in dentistry. The mild muscle-
relaxant property of these drugs is mediated at the spinal cord level, not at the 
neuromuscular junction. 
 
 
Respiratory system : Midazolam produces dose dependent respiratory 
depression. In a dosage  of 0.15 mg/kg,Midazolam significantly reduces the 
ventilatory response to CO2. In healthy patients,with small iv doses of 
midazolam 10.075 mcg/kg, the respiratory depression associated with 
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premedication is insignificant. However, the depressant effect is enhanced 
with chronic respiratory disease, and synergistic depressant effects occur 
when it is co-administered with opioid analgesics. Benzodiazepines also 
depress the swallowing reflex and decrease upper airway reflex activity. 
Transient apnea may occur after rapid injection of large doses of midazolam (> 
0.15 mg/kg IV). 
 
     
      Cardiovascular system : The predominant hemodynamic change is an 
increase in heart rate and moderate reduction in arterial blood pressure, 
resulting from a decrease in systemic vascular resistance. The mechanism by 
which midazolam maintains relatively stable haemodynamics involves the 
preservation of homeostatic reflex mechanisms. However the cardiovascular 
depressant effects are frequently “masked” by the stimulus of  laryngoscopy 
and intubation. The myocardial oxygen demand is markedly decreased but 
there is no alteration of myocardial contractility. There is also a decreased 
left ventricular end diastolic pressure (LVEDP), reflecting a decreased 
preload.Coronary vascular resistance is not altered. Coronary perfusion 
pressure is decreased, as reflected in a minimal fall in diastolic artery pressure. 
Conclusion is that good stability is observed. Systolic and diastolic blood 
pressure and pulse rates are not significantly altered. 
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   Other  effects : 
  
o Attenuates stress related epinephrine increase, which is minimal. 
  
o Plasma cortisol levels decrease from approximately 12.5 to 7.5 g/ml 
  
o Adrenocorticotropic hormone (ACTH) changes are minimal.  
o Decreases intraocular pressure 
         
   
 
 
     Clinical uses : 
 
  
Midazolam is the most commonly used benzodiazepine for 
preoperative medication in pediatric patients, IV (“conscious”) sedation 
and induction of anaesthesia. It is also used for maintenance of anaesthesia 
along with other drugs, and as an anticonvulsant. 
 
  
        DOSAGE 
 
     ROUTE 
 
 
Induction  
 
   
   0.15-0.40mg/kg 
 
         
         i.v 
 
 
Maintainence  
 
 
   0.25-1mcg/kg/min 
 
 
        i.v 
 
 
Premedication 
 
 
   0.07-0.10 mg/kg 
   
       
        i.m 
   
 
   0.25-0.5 mg/kg 
      
 
        oral 
 
 
   0.2-0.3 mg/kg 
 
 
        nasal 
 
 
I.v sedation 
 
 
    0.35mg/kg 
 
 
       Rectal 
 
 
    0.05-0.15mg/kg 
 
 
       i.v 
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1. Preoperative medication : 
 Oral midazolam 0.5 mg/kg 30 minutes before induction provides reliable 
sedation and anxiolysis in children without producing delayed recovery. 
 Intramuscular – 0.05 – 0.1 mg/kg is also effective but less well      
accepted by children. 
 Transmucosal (sublingual) midazolam is as effective as and better    
accepted than intranasal route in dose of 0.2 mg/kg. 
 Jet injection (i.e. using compressed gas instead of a needle) 0.10-0.15  
mg/kg produces effective and rapid sedation in children without 
emotional trauma associated with needle injections. 
 
 
2. Intravenous sedation : Midazolam in doses of 0.05mg/kg IV is 
effective for sedation during regional anaesthesia as well as for brief 
therapeutic procedures. Compared with diazepam, it produces a more rapid 
onset, with greater amnesia and less post-operative sedation. Pain on 
injection and subsequent venous thrombosis are less likely with midazolam 
as it is water soluble. 
 
 
3. Induction of anaesthesia : Midazolam is the benzodiazepine of choice for 
use in anaesthetic induction which is defined here as unresponsiveness to 
command and loss of eyelash reflex. In appropriate doses induction occurs less 
rapidly than with thiopental but the amnesia is more reliable. Usual 
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induction dose is 0.1 to 0.4mg/kg or lesser (0.05 – 0.15 mg/kg) in 
premedicated patients or when co-induced with other agents such as opioids, 
thiopental or propofol. 
 
4. Maintenance of anaesthesia : It is a useful hypnotic-amnesic during 
maintenance of general anaesthesia but cannot be used alone for the same. 
It is used with opioids, propofol and or inhaled anaesthetics. MAC of 
volatile anaesthetics are decreased in a dose dependent manner. It can also be 
used as an infusion in a dose of 0.25-1 g/kg/min. 
 
5. As an anticonvulsant for the treatment of grandmal seizures which may 
occur with systemic toxicity produced by local anaesthetics. 
 
     6. Conscious sedation : Midazolam is probably the only sedative to produce  
a true state of “conscious sedation”. It provides relief of anxiety and 
anterograde amnesia when administered prior to 
o Dental or minor surgical procedures 
  
o Upper GI endoscopy 
  
o Bronchoscopy 
  
o Cardiac surgery 
  
o Critically ill patients in ICU. 
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Adverse effects : 
  
 Benzodiazepines are remarkably safe drugs in doses routinely used 
 
 Most significant problem with midazolam is respiratory depression 
when the drug is given for conscious sedation. 
 When used as sedatives or for induction and maintenance of 
anaesthesia, they can produce an undesirable degree or prolonged 
interval of post operative amnesia, sedation and rarely respiratory 
depression. The residual effects can be reversed with flumazenil. 
 Rarely loss of head control and balance, blurred vision and dysphoria 
may be seen. 
 
 
 
 
       Drug interactions : 
 
  
 Alcohol, narcotics, sedatives and volatile anaesthetic agents 
potentiate CNS and circulatory depressant effects.  
 Erythromycin, ranitidine, diltiazem, fluconazole, grape fruit juice, 
verapamil and roxithromycin, increase serum levels and toxic effects. 
 Serum levels are decreased by carbamazepine, phenobarbitone, 
phenytoin and rifampicin. 
 It decreases MAC for volatile agents 
  
 Effects are antagonized by flumazenil. 
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Precautions : 
  
 Reduce the dose in elderly, hypovolemic, high risk patients, and with 
concomitant use of other sedatives or narcotics. 
 COPD patients are unusually sensitive to the respiratory depressant 
effect. 
 
 It is contraindicated in acute narrow angle or open angle glaucoma. 
  
  It is excreted in human milk, therefore caution should be exercised  
 
when it is administered to a nursing woman. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
37 
 
 
 
       PHARMACOLOGY OF BUPIVACAINE16,17,18  
  
Source : Bupivacaine was synthesised by A.F. Ekenstam and his collegues in 
Sweden in 1957. 
 
Chemistry : The molecular weight of the chloride salt is 325 and that of 
the base form is 288. It has a melting point of 2580C. Solutions containing 
epinephrine have a pH of about 3.5.The chemical name is 1-n-butyl-DL-
piperidine-2 carboxylic acid-2, 6 dimethylamilide hydrochloride. 
The molecular formula is C18N2OH28HCl.   
                                          
CH3- 
 
 
 
 
NHCO 
 
N 
| 
C4H9 
 
CH3 
 
 
Chemical structure 
  
 
Derived from mepivacaine which has a methyl group on the piperidine N2 atom  of 
the molecule.Addition of a butyl group to piperidine N2 atom of mepivacaine forms 
bupivacaine.Bupivacaine is 3.5 times more lipid soluble and 2.4 times more potent 
than mepivaciane 
 
38 
 
Bupivacaine Hydrochloride is available in sterile isotonic solutions with and 
without epinephrine (as bitartrate) 1:200,000 for injection via local infiltration, 
peripheral nerve block, and caudal and lumbar epidural blocks. Solutions of 
bupivacaine hydrochloride may be autoclaved if they do not contain epinephrine. 
Solutions are clear and colorless. 
Bupivacaine is related chemically and pharmacologically to the aminoacyl 
local anesthetics. It is a homologue of mepivacaine and is chemically related to 
lidocaine. All three of these anaesthetics contain an amide linkage between the 
aromatic nucleus and the amino, or piperidine group. They differ in this respect 
from the procaine-type local anesthetics, which have an ester linkage.Bupivacaine 
Hydrochloride Injection USP is available in sterile, isotonic solutions containing 
bupivacaine hydrochloride in water for injection with characteristics as follows: 
 
Table-B :Bupivacaine Hydrochloride Injection, USP (without epinephrine) 
 
Concentration Bupivacaine Hydrochloride 
          (mg/mL) 
 
 
Sodium Chloride mg/mL 
 
0.25% 2.5 8.6 
 
0.5% 5 8.1 
 
0.75% 7.5 7.6 
 
 
May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. 
Multiple-dose vials contain methylparaben 1 mg/mL added as a preservative. 
Bupivacaine and Epinephrine Injection, USP is available in sterile, isotonic 
solutions containing Bupivacaine hydrochloride and epinephrine 1:200,000 with 
characteristics 
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Table-C  : Bupivacaine and Epinephrine Injection, USP 
 
 
Concentration 
(Bupivacaine HCL) 
 
Bupivacaine 
Hydrochloride 
(mg/mL) 
 
Epinephrine 
1:200,000 
(mcg/mL) 
 
Sodium 
Chloride 
(mg/mL) 
0.25% 2.5 5 8.5 
0.5% 5 5 8.5 
0.75% 7.5 5 8.5 
 
 
 
Sodium metabisulfite 0.1 mg/mL added as antioxidant and edetate calcium 
disodium,anhydrous 0.1 mg/mL added as stabilizer. May contain sodium 
hydroxide and/or hydrochloric acid for pH adjustment .Multiple dose vials contain 
methylparaben 1 mg/mL added as a preservative. Single-dose solutions contain no 
added bacteriostat or anti-microbial agent and unused portions should be discarded 
after use 
 
 Physiochemical properties : 
  
1) Solubility : The base is sparingly soluble, but the hydrochloride is readily 
soluble in water. 
2) Stability and sterilization : Bupivacaine is highly stable and can  
 
withstand repeated autoclaving. 
  
3) pH of saturated solution : 5.2 
 
4) Specific gravity : 1.021 at 370C 
 
5) Pka  : 8.1 
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6)  Protein Binding : 95% 
7)  Volume of Distribution : 73 litres 
8)   Clearance : 0.47 litres 
9)  Half – life : 210 minutes 
10) Toxic plasma concentration > 3mcg/ml 
 
      USES     
                     1)Spinal anaesthesia 
                     2) Epidural anaesthesia 
                     3)Caudal anaesthesia 
                     4)Combined Spinal Epidural anaesthesia 
                     5)Peripheral Nerve Block 
 
 
      Anaesthetic properties : 
  
Potency : 
 
Bupivacaine is approximately three to four times more potent than 
lidocaine.The duration of action of its motor blockade is two to three 
times longer than lidocaine. 
        
        
 Pk  : 
        Weak base pKa > physiological pH. At a pH of 7.4, 17% of bupivacaine exists  
as   non-ionised form 
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        Placental Transfer: 
         Plasma protein binding influences the rate and degree of diffusion of local 
anesthetics across the   placenta . bupivacaine, which is highly protein bound 
(approximately 95%), has an umbilical vein-maternal arterial concentration 
ratio of about 0.32. Acidosis in the fetus, which may occur during prolonged 
labor, can result in accumulation of local anesthetic molecules in the fetus 
(ion trapping). 
         Distribution: 
 Rapid distribution phase (n this phase,the drug gets distributed to highly 
vascular region.t1/2  of mins 
Slow disapparence phase(Drug distributes  to slowly equilibrating 
tissues.t1/2 of mins 
Clearance : 0.47 mmol/min 
 
          Dosage and preparation available : 
     The dosage of Bupivacaine depends on : 
  
 Area to be anaesthetized 
  
 The vascularity of the tissue to be blocked 
  
 The number of neuronal segments to be blocked 
  
 Individual tolerance 
  
 Technique of local anaesthesia 
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  These doses may be repeated in 3-4 hours. 3 mg/kgmg is the maximum dose. 
The addition of vasoconstrictor produces a very slight increase in the 
duration of action. However the peak blood level is significantly reduced, 
there by minimizing the systemic toxicity. 
 
ACTIONS : 
 
 
 
Central nervous system : 
  
Overdose of bupivacaine produces light headedness and dizziness 
followed by visual and auditory disturbances such as difficult to focus and 
tinnitus. Disorientation and drowsiness can also occur. Shivering, muscular 
tremors and tremors of muscles of face and distal part of extremities can occur. 
Ultimately generalized tonic clonic convulsions occurs. Further increase in 
doses causes respiratory arrest. Since bupivacaine is a potent drug, smaller 
doses can cause rapid onset of toxic symptoms when compared to other 
drugs. 
 
      Autonomic nervous system : 
  
                    Bupivacaine does not inhibit the Noradrenaline uptake and hence  
                    has no sympathetic potentiating effect. Myelinated preganglionic beta 
fibres have a faster conduction time and are more sensitive to the action of 
local anaesthetics including bupivacaine. Involvement of preganglionic 
sympathetic fibres is the cause of widespread vasodilatation and 
consequent hypotension that occurs is epidural and paravertebral block. 
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When used for conduction blockade, all local anaesthetics particularly 
bupivacaine produce higher incidence of sensory than motor fibres 
blockade. 
 
    
 
          Neuro-muscular junctions : 
 
Bupivacaine like other local anaesthetics can block motor nerves if  
 
     present in sufficient concentration but has no effect on the neuromuscular    
junction as such. 
 
  
 
Cardiovascular system : 
  
The primary cardiac electrophysiologic effect of local anaesthetic is a 
decrease in the maximum rate of depolarization in the purkinje fibres and 
ventricular muscle. This is due to a decrease in the availability of sodium 
channels.Bupivacaine decreases cardiac output by decreasing sympathetic 
tone,decreasing heart rate and decreasing venous return.It also decreases 
central venous pressure.There is an increase in blood flow to lower limb with 
decrease in DVT. 
 Bupivacaine is highly arrythmogenic. The cardiac contractility is 
reduced, this is by blocking the calcium transport. Low concentration of 
bupivacaine produces vasoconstriction while higher doses causes 
vasodilatation. 
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        Respiratory system : 
    
Respiratory depression may be caused if excessive plasma level is 
reached. Respiratory depression may also be caused by paralysis of 
respiratory muscles as may occur in high spinal or total spinal anaesthesia. 
  
      Pharmacodynamics : 
            The onset of action of bupivacaine is between 4 and 6 minutes  
maximum anaesthesia is obtained between 15 and 20 minutes. The duration of 
anaesthesia varies according to the type of block, the average duration for 
peridural block is about 3.5-5 hours, for nerve blocks, it is about 5 to 6 hours. 
     
      Toxicity : 
  
            The toxic plasma concentration is set at 4-5g/ml. Maximum 
plasma concentration rarely approach toxic levels. Non specific local irritant 
effects on nerve tissue have been noted in human subjects. No evidence of 
permanent damage has been found in clinical dosage. 
 
 
      Pharmacokinetics : 
  
             Bupivacaine can be detected in the blood within 5 minutes of 
infiltration or following either epidural or intercostal nerve blocks. Plasma 
levels are related to the total dose administered. Peak levels of 0.14 to 1.18 
g/ml were found within 5 minutes to 2 hours after the administration of 
anaesthesia and they gradually declined to 0.1 to 0.34g/ml by 4 hours. 
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Plasma binding : 
  
         In plasma, drug binds avidly with protein (1- acid glycoprotein) to the 
extent of 70-95%. The rank order of protein binding for this and its 
homologues is- bupivacaine<mepivacaine<lidocaine. Conversely, the 
unbound active fraction is one seventh that of lidocaine and one fifth that of 
mepivacaine. 
 
       Metabolism : 
  
Because bupivacaine is an amide, the liver is the primary site of 
metabolism. The drug is metabolized partly by N-dealkylation primarily to 
pipecolyloxylidine. N-disbutyl-bupivacaine and 4-hydroxy-bupivacaine are 
also formed. It crosses the placental barrier as any other local anaesthetic 
by passive diffusion, but the lowest level of placental diffusion is reported 
for this drug (umbilical vein/maternal ratio is 0.31 to 0.44). The high protein 
binding capacity of the agent is probably the reason why less diffusion occurs 
across the placenta. No effects on fetus have been noted. 
 
     Excretion: 
  
         About 10% of drug is excreted unchanged in urine within 24 hours; 
5% excreted as pipecolyloxylidine. Glucoronide conjugate is also excreted. 
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Adverse reactions : 
  
                    Adverse reactions occur with excessive plasma levels which may be 
due to overdose, inadvertent IV injections or slow metabolic degradation. 
These manifest by effects on CNS and CVS. The CNS effects are 
characterized by excitation or depression. The first manifestation may be 
nervousness, dizziness, blurring of vision or tremors following drowsiness, 
convulsions unconsciousness and probably respiratory arrest. 
 
         Other effects may be nausea, vomiting, chills, constriction of pupils   
and tinnitus. The CVS manifestations include myocardial depression, 
hypotension and cardiac arrest, in obstetrics fetal bradycardia may occur. 
Allergic reactions include urticaria, bronchospasm and hypotension. 
 
 
Treatment of adverse reaction : 
  
Treatment is mainly symptomatic. After initiation of basic life support 
and the ACLS protocol ,a rapid bolus of Intralipid 20%, 1.5 mL/kg (or roughly 
100 mL in adults), be administered without delay, followed if necessary by an 
infusion of 0.25 mL/kg/min for the next 10 minutes. (recommendation of 
Weinberg and colleagues ). Clinicians should make a routine practice of having 
the following ready at hand: monitoring equipment; an oxygen tank or wall 
oxygen outlet; airway equipment, including at minimum, a bag-mask circuit for 
delivery of positive-pressure ventilation; and drugs to terminate convulsions, 
such as midazolam, lorazepam, diazepam, or thiopental.  Treatment of 
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ventricular fibrillation and tachycardia by amiodarone (5mg/kg iv) or 
defibrillation (2-6 joule/kg). 
 
      Cardiovascular collapse / CNS ratio : 
 
        The CC/CNS dose ratio for Bupivacaine is 3.7 0.5 or findings  
indicating that 3 times drug was required to induce irreversible 
cardiovascular collapse as was needed to produce convulsions. It has also 
been suggested that some of the enhanced cardiac toxicity of Bupivacaine is 
due to greater myocardial uptake. 
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REVIEW OF LITERATURE : 
 
 
 
   1. Edwards et al19 (Anaesthesiol 1990;73:273-7)
 
conducted a randomised 
control study in rats to find out the mechanism by which midazolam causes 
spinally mediated analgesia.In this study the electrical current  thresholds for 
pain (ECTP) in the skin  of the neck and tail were measured with 
chronically implanted  subarachnoid catheters. Segmental analgesia following 
midazolam was  attenuated (P<0.05) when the selective GABA antagonist 
bicuculline was given intrathecally at the same time as midazolam. The 
highest dose of bicuculline used, caused no significant attenuation of the 
segmental analgesic effects of either fentanyl or ketocyclazocine. They  
concluded that segmental analgesia produced by intrathecal midazolam is 
mediated by benzodiazepine–GABA receptor complex that is involved in other 
benzodiazepine actions.
 
 
                                             
         2. Batra YK et al20 (Int. Journal Clinical Pharmacol 1999;37:519-23)  
conducted a randomised double blinded control study to find out the effect 
of intrathecal midazolam added to bupivacaine for knee arthroscopy.In this 
study, 30 healthy patients of ASA-I and ASA-II scheduled for knee 
arthroscopy  were divided into two groups of 15 each.Group M received 
Inj.midazolam-bupivacaine mixture (midazolam 50mcg/kg+bupivacaine 
(0.5%)17.5gm/3.5ml) .Group B received Inj.bupivacaine(0.5%) alone 
(bupivacaine 17.5gm/3.5ml) intrathecally. They recorded the level of sensory 
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block, sedation score, assessment of pain using   visual analogue score  in both 
groups at regular time intervals. Time to block regression, recovery to 
ambulation and ability to void were recorded and noted before discharged.  
                       
                        A significantly higher Visual Analogue score (P < 0.05) was 
seen  in group B. All patients in group B received rescue analgesia at a mean 
duration of 258  4.68 minutes where as only one patient in group M 
required supplemental analgesia within this period. Time to regression of 
sensory analgesia was longer in group M (P< 0.05). Neither motor block 
nor time to void were prolonged with the addition of midazolam to 
bupivacaine. They  concluded that addition of intrathecal midazolam to 
bupivacaine provides better postoperative analgesia without prolonging motor 
blockade. 
 
                                 
3.     Kim M, Lee Y et al 21 –  British Journal 2001:86:77-79   
       A double blind study was conducted to evaluate the post-operative  analgesic 
effects of intrathecal midazolam with bupivacaine following    
haemorrhoidectomy. 45 patients were randomly allocated to one of the three 
groups. The control group received 1ml of 0.5% heavy bupivacaine plus 
0.2ml of 0.9% saline intrathecally, group BM1 received 1ml of 0.5% 
bupivacaine plus 0.2ml of 0.5% preservative free midazolam and group BM2   
received 1ml of 0.5% bupivacaine plus 0.4 ml of 0.5% midazolam. Time to  
first analgesia was significantly greater in the midazolam groups than in the 
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placebo and significantly less in BM1 group than in BM2 group. They 
concluded that intrathecal midazolam increased the analgesic effects of spinal 
blockade with bupivacaine.
 
 
4.  Tucker A P et al 22 (Anaesthesia Analgesia 2004; 98:1521-7) conducted  a 
p rospec t ive  double  b l i nd  study to evaluate the ability of intrathecal 
midazolam to increase the potency and duration of the analgesic effects of 
intrathecal fentanyl, without producing adverse effects. 30 parturients of 
ASA I and ASA II with cervical dilatation 2-6cm were randomized to 
receive either intrathecal midazolam 2mg, fentanyl 10g or both combined 
to initiate analgesia.  Pain scores were recorded before and at 5-min 
intervals for 30 min after the injection and then every 30 min until the 
patient requested further analgesia. The presence and severity of nausea, 
emesis, pruiritus, headache and sedation, in addition to arterial blood 
pressure, heart rate, respiratory rate, sensory changes to ice, motor 
impairment, cardiotocograph and apgar score were also recorded.They 
concluded that intrathecal midazolam potentiated the analgesic effect of 
fentanyl. It did not increase the occurence of any maternal adverse events 
or abnormalities on the cardiotocography. 
 
 
 
5.  Yokoyama et al 23 
 
in 1998 (Canadian journal of Anaesthesia 
1998;45:551-5)conducted a prospective randomised controlled study was 
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conducted to investigate the effect of midazolam on  epidural  infusion of 
bupivacaine. 60 patients of ASA I and ASA II scheduled for gastrectomy were 
divided into 3 groups of 20. The following mixtures, in 40 ml, were  infused 
continuously over 12 hours after surgery; 40ml bupivacaine 0.5% in group C, 
bupivacaine 0.5% 38ml + 10mg  midazolam in group M10  and   bupivacaine 
0.5% 36 ml + 20mg of midazolam  in  group M20.  Better  analgesia was 
obtained in patients receiving midazolam than in group C (P < 0.05). Frequency 
of rescue analgesics administration was greater in  group C (P < 0.05). Greater 
sedation was seen in groups M10 and M 20 during  first  120 minutes without 
any respiratory depression, which was desirable in the postoperative period. 
They concluded that adding midazolam to a continuous epidural infusion of 
bupivacaine provides better analgesia and sedation than bupivacaine alone 
without side effects in  patients  undergoing  laparatomy.
 
 
6. Nishiyama et al 24 (J Clinical Anaesthesia 2002;14(2):92-97) conducted 
a prospective randomized double-blinded study  to investigate the 
interaction of midazolam with different doses of bupivacaine, by 
comparing the analgesic, sedative and amnesic effects of continuous  
epidural midazolam with two different does of bupivacaine. 100 ASA I 
and II post gastrectomy patients without any complications were divided  
in 4 groups  (n = 25)  and  administered thoracic  epidural  infusion  (40 ml 
/ 12 hour) of the drugs via a balloon infuser.  
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           The contents of the infuser (40ml) were bupivacaine, 180mg with 
midazolam 20mg (HM group), bupivacaine, 90mg with midazolam 20mg 
(LM group), bupivacaine, 180mg without midazolam (HC group) and 
bupivacaine, 90mg without midazolam (LC group). It was found that HM 
group had significantly better analgesia and sedation. The time to the first 
rescue medication was longest in HM group followed by LM, then HC and 
finally LC groups. The number of patients with amnesia were greater in HM 
and LM groups. They concluded that adding  midazolam increased not only 
the analgesic but also the sedative effect with increasing dose and 
bupivacaine in a post operative continuous epidural administration.
 
          
 7.Mahajan R,Batra YK, 25
 
Int J Clin Pharmacol Ther2001;39(3):116-20 
 
           A double-blinded study was designed to evaluate the analgesic efficacy of 
caudal midazolam- bupivacaine combination in providing post-operative pain 
relief in children undergoing genito-urinary surgery and to study the occurence 
of side effects . Thirty children, aged 2 to 8 years, scheduled  for genito-
urinary surgery were allocated randomly to receive either 0.25% bupivacaine 0.5 
ml/kg (group B; n = 15) or 0.25% bupivacaine 0.5ml/kg with 50 g/kg 
midazolam (group BM; n = 15) by caudal route immediately after induction of 
general anaesthesia. Lowest pain scores were observed with the addition of 
midazolam to caudal bupivacaine (p < 0.01). Duration of analgesia was longer 
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in group BM (11 0.5h) as compared to group B (7.4  2.1h) (p < 0.05). No 
significant changes in heart rate, blood pressure and oxygen saturation was 
observed. The authors concluded that caudal administration of midazolam – 
bupivacaine mixture prolongs post-operative analgesia compared to 
bupivacaine alone without any adverse effects. 
 
8.    Culebras X, Van Gessel 4
 
(Anaesth Analg 2001;92:199-204)                       
A prospective randomized double blinded study was conducted to  
determine the efficacy and adverse effects of clonidine,when mixed with 
a long acting local anaesthetic on postoperative analgesia. 60 adult patients 
o f  A S A  I  a n d  I I  undergoing rotator cuff repair under interscalene 
brachial plexus block were included in the study. The study group  received 
150g of  clonidine with   40ml of  0.5%  heavy bupivacaine. It was found 
that   duration of analgesia was unaltered but  the mean arterial pressure and 
heart rate were significantly decreased in clonidine group. They concluded that 
clonidine,as an adjuvant  in brachial plexus block does not improve post 
operative analgesia  but does induce haemodynamic changes.
 
 
 9. Morris M.E et al27 (Brain Res 1983;278(1-2):117-26) conducted  a randomised 
controlled study in which  the inhibitory neurotransmitter GABA has been 
shown to  have a depolarizing action on myelinated axons of both 
mammalian  and amphibian peripheral nerves. In initial in-vivo observations  
55 
 
intravenous injections of GABA caused an increase in excitability of   the    
low threshold fast conducting fibres of the superficial radial and median  nerves 
of cat. Similar, graded, reversible effects were confirmed (using changes in the 
amplitude / integral of the stimulus evoked A fiber submaximal compound action 
potential to assess excitability) in in-vitro studies with the isolated, desheathed 
frog sciatic nerve. GABA caused a mean maximal increase in half-maximal action 
potential of 29.8% (S.E. 2.7), with an ED50 value of 0.09 mM and hill 
coefficient of 0.70.. They concluded  that extrasynaptic receptors of GABA are 
present on myelinated axons of peripheral nerves 
 
10.  Jarbo K  et al 28
 
(Canadian journal of anaesthesia 2005 :52:822-6)                             
conducted a prospective randomized double blind study  to  assess the effect of 
midazolam added to brachial plexus block.This study was conducted  on 40  
ASA I and II adult patients undergoing upper limb surgeries under 
supraclavicular brachial plexus block.. Patients in group B (n = 20) were 
administered 30ml of 0.5% bupivacaine and group BM (n = 20) were given 
30ml of 0.5% bupivacaine with midazolam /kg.Haemodynamic variables 
(i.e., heart rate, noninvasive  blood pressure), pain scores and rescue analgesic 
requirements were recorded for 24 hr postoperatively. The onset time and 
duration of sensory and motor blockade were recorded. The onset of sensory 
block  was significantly faster in group BM (12±2.9 mins) when compared to 
group B (20+3.8).Th i s  r e su l t  was  s ta t i s t i ca l l y  s i gn i f i can t  (P < 0.05). 
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The onset of  motor block  was significantly faster in group BM (9.2 ± 2.38 mins) 
when compared to group B (17.1+3.83).Thi s  r esu l t  was  s t a t i s t i ca l l y 
s i gn i f i can t (P < 0.05). The  du ra t i on  o f  mo to r  b l ock ade  was  no t  
d i f f e ren t  i n  t wo  g roups  . In  Group  B ,  t he  du ra t i on  o f  mo to r  
b lock ade  was  5 .1  +  1 .14  wh i l e  i n  Group  BM , the  du ra t i on  o f  
mo to r  b lock ade  wa s  5 .6 + 3.32. Th i s  r e su l t  was  s t a t i s t i ca l l y 
i n s ign i f i can t  (P  > 0.05). Pain scores were significantly higher in group B 
compared to group BM from two hours to 24 hrs postoperatively (P < 0.05). 
Rescue analgesic requirements were significantly less in group BM compared 
to group B (P < 0.05). Haemodynamics and sedation scores did not differ 
between groups in the postoperative period. They concluded that Midazolam 
(0.05mg/kg) in combination with 30ml of bupivacaine (0.5%) hastened onset of 
sensory and motor block, and improved postoperative analgesia in brachial 
plexus block, without producing any adverse effects. 
 
    11.        Naguib M et. al 29(Can J Anaesthesia 1995;42:758-64) conducted a 
randomized double-blinded study,in which they compared the efficacy of 
midazolam with bupivacaine for caudal analgesia in children undergoing inguinal 
herniotomy. They were allocated randomly into three groups (n = 15 in each) to 
receive a caudal injection of either 0.25% bupivacaine 1 ml/kg
 
 with or without 
midazolam 50 μg /kg or midazolam 50 μg/ kg with normal saline 1 ml/kg. There 
were no differences in quality of pain relief, postoperative behaviour or analgesic 
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requirements between the midazolam group and the other two groups. Times to 
first analgesic administration (paracetamol suppositories) were longer (P < 0.001) 
in the bupivacaine-midazolam group than in the other two groups. Further, the 
bupivacaine-midazolam group received fewer (P < 0.05) doses of paracetamol 
suppositories than the bupivacaine group. Side effects such as motor weakness, 
respiratory depression or prolonged sedation were not observed in patients who 
received caudal epidural midazolam only. They concluded that caudal midazolam 
in a dose of 50 μg /kg provides equivalent analgesia to bupivacaine 0.25% of 
1ml/kg when administered postoperatively in a volume of 1 ml/kg for children 
following unilateral inguinal hemiotomy. 
      
12 . Nishikawa K ,Kanaya N,Nakayama M 30
 
(Anaesth Analg 2000;91(2):384-7 
conducted a double-blind study to evaluate the effect of fentanyl added to 
lidocaine for  axillary brachial plexus block in 66 adult patients of ASAI & II 
scheduled for elective  hand and forearm surgeries. The duration of sensory 
blockade was significantly increased in fentanyl group (323  96 min) as  
compared to the control (250  79 min)group. However the onset  time of 
sensory blockade was  prolonged , due to decreased pH of fentanyl. 
 
 
 13. R Hickey, Joan Hoffman et al 31(Anaesthesiology 74:639-342, 1991) 
conducted a double blind study to compare the efficacy of 0.5% ropivacaine and 
0.5% bupivacaine for brachial plexus block.48 patients received a subclavian 
perivascular brachial plexus block for upper extremity surgeries. One group 
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received(n=24) 0.5% plain ropivacaine 175mg and second group received (n=24) 
0.5% plain bupivacaine 175mg . The block was performed using Winnie’s 
technique by eliciting paresthesia. Sensory block, motor block , duration of 
analgesia, duration of anaesthesia and side effects were evaluated. They concluded 
that ropivacaine and bupivacaine 0.5% were equally effective in providing brachial 
plexus block  in the onset and duration of motor and sensory block, incidence of 
adverse events and the need for supplementation with rescue analgesics. 
 
14. Gulec et al 32(European Journal of Anaesthesiol 1998;15:161-5)  conducted 
a prospective double blind randomised control study to find out the efficacy of  
bupivacaine-midazolam mixture to bupivacaine – morphine mixture to prolong  
post-operative analgesia in caudal  block.In this study,60 children undergoing 
inguinal or urogenital surgery were randomly divided into three groups of 20 
each.Group I received caudal injection of bupivacaine 0.125% 0.75ml/kg with 
midazolam 50 mcg/kg.Group II received Inj.bupivaciane 0.125% with Inj. 1% 
morphine  0.05 mg/kg.Group III received Inj.bupivacaine 0.125% alone.There 
were no significant changes in heart rate,blood pressure,respiratory rate or oxygen 
haemoglobin saturation.There were no significant differences in the incidence of 
vomiting and pruritis between the groups(P>0.05).Sedation scores were higher in 
bupivacaine-morphine group and bupivacaine-midazolam group(P<0.01).The 
durations of analgesia were 21.15+ 1.2 hrs in bupivacaine-midazolam 
group,14.50+ 1.6 hrs in bupivacaine-morphine group and 8.15+ 1.3 hrs in 
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bupivacaine group.The difference between plain bupivacaine and bupivacaine-
midazolam group was statistically significant(P<0.001),bupivacaine-midazolam 
and bupivacaine-morphine group was  also significant(P<0.01).They concluded 
that caudal administration of bupivacaine-midazolam mixture produces  a     longer 
duration of post-operative analgesia than bupivacaine-morphine or bupivacaine 
alone with sedation for 8-12 hours.                       
 
15.Serraro J M et al 33 (Pain 1992;48:5-12) conducted a prospective, double 
blind, randomised and dummy-controlled trial in 28 patients with chronic 
mechanical low back pain presenting to the York Pain Clinic. The therapeutic 
effects of epidural methyl prednisolone (80 mg) were compared with intrathecal 
midazolam (2 mg). The two groups of patients were comparable in terms of pain 
duration, demography, extent of disability, anxiety and depression and pain locus 
of control. The pain was assessed before and for 2 months after treatment using the 
short form McGill Pain Questionnaire as well as visual analogue and verbal rating 
scales for sensory and affective components of their pain experience..They  found 
out that all the patients treated with steroid were  taking more or the same amount 
of self-administered analgesic medication during the 2 month follow-up period. 
But one-half of midazolam-treated patients took less medication during the 2 
month follow-up period. They concluded that intrathecal midazolam is an effective 
treatment for chronic mechanical low back pain.
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16.Shaikh S et al34 (Anaesthesia,Pain and Intensive Care 2012;16(1):7- 11 
conducted a prospective, randomized, double blind study to find out the effects of 
Inj. midazolam added to bupivacaine in supraclavicular brachial plexus block. This 
study was done in 50 adult patients of ASA I and II, aged between 18-65 
years,who were  scheduled for various   upper limb surgeries.  Patients were 
divided into two groups of 25 each. Group B received    30ml of Inj. bupivacaine 
0.5% +2ml normal saline and group BM received 30ml      of Inj. bupivacaine 
0.5% + inj. midazolam (preservative free) 0.05mg/kg. Patients were observed for 
sedation, respiratory depression, pulse rate, SBP, DBP, duration    of motor block, 
duration of pain relief and occurrence of any complications.Post operative 
analgesia was significantly longer (805.04175.75 min) in group BM, as compared 
to group B (502.2452.68 min) with p value  <0.001. Pain   score    was 
significantly low in group BM (mean 1.6), compared to group B (mean 4.92) at 12 
hours postoperatively. Onset of sensory block was 8.36+3.58 min and 8.52+ 4.18 
min  in group B and group BM respectively with     p value  >0.05.    Hence there 
was     no statistically significant difference. Onset of motor block in   group B    
was 9.96+5.69 min and in group BM was 7.92 +5.68 min. and p value was >0.05 
min. This  was not statistically significant . Mild respiratory depression and 
sedation occurred intraoperatively in group BM which required no active 
intervention. In.brachial  plexus block, addition of  Inj.midazolam  50 mcgs/kg  to 
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30ml of 0.5% bupivacaine improved post operative  analgesia   and prolonged 
sensory blockade without producing any adverse  effects.   
17. Tucker A P et al35 (Anaesthesia Analgesia 2004;98:1512-20) conducted a 
cohort study which evaluated the potential of midazolam to produce symptoms 
suggestive of neurological damage.This study compared cohorts of patients who 
received intrathecal anaesthesia with or without intrathecal midazolam(2 mg).They 
evaluated eighteen risk factors regarding the symptoms with respect to the  
potential neurological complications.1100 patients were followed up prospectively 
during the first postoperative week by a hospital chart review and one month later 
by a mailed questionnaire. Any symptoms suggestive of neurological 
impairement,like motor or sensory changes,bladder or bowel dysfunction were 
evaluated.They found out that intrathecal (2 mg) was not associated with an 
increased risk of neurologic symptoms in contrast to preclinical studies done in 
animals. 
18. Nishiyama et al36
 
(Anaesthesia Analgesia 1999;89:717-20) conducted a 
randomised control  study in cats  to investigate the acute histopathological  effects 
of intrathecal  midazolam.They did the study in 40 cats divided into 2 groups of 
20.The first group was given midazolam 10 mg(2ml) and the second group was 
given saline 2ml.After 1,2,4, or 6 hours after administration,these cats were killed 
and histology report was examined using light microscopy.Inflammatory changes 
were only seen in cats in the saline group.In conclusion,upto 6 hrs after direct 
exposure to midazolam,no inflammatory damage was seen. 
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19. Vandana Trivedi et al37
 
[J Indian Med Assoc 2010; 108: 563-7] conducted  a 
study to compare the effects of midazolam and clonidine added to bupivacaine. A 
randomised controlled clinical trial was conducted for 60 ASA I-II  presenting for 
elective upper limb orthopaedic surgeries of duration of less than120 
minutes.They were divided into 2 groups of 30 each, Group C receiving clonidine 
and Group M receiving preservative free Inj.midazoalm. All were premedicated 
with injection glycopyrrolate 0.2mg intramuscular 30 minutes before surgery and  
injection bupivacaine 0.5% plain 20 ml and injection lignocaine 2% plain 10 ml 
in supraclavicular brachial plexus block. In group C patients injection clonidine 
150 mcg and in group M injection midazolam preservative free 5 mg were 
administered along with local anaesthetics. All the patients were observed for 
onset and duration of sensory and motor blockade, sedation score, postoperative 
analgesia with visual analogue scale  score up to 12 hours. The mean time for 
onset of sensory blockade in clonidine group was 6.08 ±  1.67 mins while in 
midazolam group,was 6.33 ±  0.99 mins,p value was 0.5.51,hence not 
significant(p>0.05).The mean time for onset of motor blockade in clonidine group 
was 9.3 ± 2.02 mins while in midazolam group, was 10.13+0.89 mins.The p value 
was found out to be 0.15,hence not significant.The mean duration of motor 
blockade in group C was found out to be 4.5 ± 0.41 hours while in group M, was 
4 ± 0.35 hours,p value was found to be 1.19,hence not significant.The mean 
duration of sensory blockade was 4+0.36 hours,while in group M,was 
3.5+0.30.The p value was found to be 1.068,hence not significant. Sedation score 
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was more in group C(score of  2)when compared to group M(score of 1).Post 
operative analgesia was more in group C(VAS score of <3 in 300 mins) when 
compared to Group M (VAS score of > 3 in 300 mins). No complications were 
observed in any one of  patient in both the groups. So injection clonidine provides 
better postoperative analgesia and more sedation than midazolam.  
 
 
20. Nasreen Laiq, Mohammad Naeem Khan, Mohammad Arif and Shahid 
Khan38
 
(Journal of the College of Physicians and Surgeons Pakistan 2008, 
Vol. 18 (11): 674-678):This randomised controlled clinical trial  was done to 
compare the onset, duration and postoperative pain scores in  supraclavicular 
block with bupivacaine alone and bupivacaine-midazolam combination.This 
study was conducted in 50 ASA I and II adult patients undergoing upper limb 
surgeries under supraclavicular block. Patients were randomly allocated into two 
groups of 25 each. 
 Group A -30 ml of 0.5% Inj.bupivacaine  
 Group B were given 30 ml of 0.5% Inj.bupivacaine with midazolam 50 µg/kg.  
Hemodynamic variables (heart rate, noninvasive blood pressure, oxygen 
saturation), pain scores, rescue analgesic requirements and sedation score were 
recorded for 24 hours postoperatively.They found out that the onset of sensory  
blockade was significantly faster in Group B(14±3.1) when compared to Group 
A(22±3.5)(P value<0.01)They also found that onset of motor blockade was 
significantly faster in Group B (10.5+2.40) when compared to Group 
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A(18.5+3.1)The post-operative analgesia was significantly prolonged in Group 
B(9.30+4.50 )than in group A(6.20+1.8),p value <0.01,hence statistically 
significant.The duration of motor blockade was significantly prolonged in Group 
B(7.65+3.20) when compared to Group A(5.20+2.10)The number of rescue 
analgesics  required  were  also  less  in  group B  when  compared  to  group  A. 
Hemodynamics and sedation score were also similar in both  the groups.They 
concluded that addition of Inj.midazolam to bupivacaine in supraclavicaular 
brachial plexus block fastened the onset of sensory and motor blockade and 
provided prolonged post operative analgesia without producing any adverse 
effects. 
 
    21. Sibel Baris et al 39 (Pediatric Anesthesia Volume 13, Issue 2, pages 126 -
131, February 2003)   This randomised control study was conducted  to 
evaluate the intensity and    efficacy of 0.75 ml/kg bupivacaine 0.25% with the 
addition of fentanyl or midazolam for caudal block in children undergoing 
inguinal herniorrhaphy.In this study, 75 ASA I & II patients were allocated 
randomly into 3 groups of 25 each Group B –bupivacaine (plain  )0.25%, Group 
BM- bupivacaine-midazolam (50mcg/kg), Group BF- bupivacaine-
fentanyl(1mcg/kg) after induction of anaesthesia. Haemodynamic parameters, 
pain score, additional analgesic requirements and side-effects were noted. The 
mean systolic arterial pressure at 10, 20, 30 min after caudal block was higher in 
group B when  compared with groups BF and BM. Mean intraoperative heart 
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rate was lower in group BF than the other groups. Adequate analgesia was 
obtained in all patients (100%) in group BF, 23 patients (92%) in group BM and 
21 patients (84%) in group B (P > 0.05), hence not significant. The time to 
recovery to an aldrete score of 10 was significantly shorter in group B than in 
group BM (P < 0.05). and in  group BF(P value>0.05). There was no difference 
in additional analgesic requirements between the groups in the first 24 h. 
Sedation score was higher in the BM group at 60 and 90 min postoperatively 
than the other groups.They concluded that in caudal block, the addition of 
fentanyl(1 mcg/kg) or midazloam(50mcg/kg) as adjuvants to bupivacaine do not 
provide any further analgesic requirement when compared to 0.75 ml/kg 
bupivacaine (0.25% ) alone. 
 
 
22. A.Kharbasfrushan et al40
 
(Iranian  Red Crescent Med J. May 2012; 14(5): 
276–282).This prospective double blind randomised control study was done to 
assess the effect of intrathecal midazolam to reduce  the severity of pain in 
caesarean section.In this study 124 ASA I and II parturient females were assigned 
into 2 groups of 62 each. Women in the experimental group received bupivacaine 
(10 mg) plus intrathecal midazolam (2 mg/ml) (BM) and those in the control group 
received bupivacaine plus normal saline (BNS).The pain severity was measured 
using a verbal numerical rating scale.In group BM, the patients had significant pain 
relief during 15 and 120 mins after surgery.But there was no significant difference 
during 5,30,60,240 mins after surgery. The average time until the first dose of 
additional analgesic was 142.18±55.19 min in the BNS vs 178.06±77.33 min in the 
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BM group. They concluded that combination of bupivacaine (10 mg) plus 
intrathecal midazolam (2 mg) was an effective anesthetic technique to proI,ide 
improvement in pain. The onset of sedation was faster in the group that received 
bupivacaine plus intrathecal midazolam compared with those who received 
bupivacaine plus normal saline. 
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METHODOLOGY 
 
 
Study Design                   :  Prospective Single Blinded Case Control Study.  
Sample Size                 : 100 patients 
Sampling Method        : Randomised sampling 
Statistical Analysis     : Student’s ‘t’ test was used to test the significance of     
difference between quantitative variables and Yate’s chi 
square test was used for qualitative variables 
Method of collection : All patients  undergoing elective upper limb  surgery 
 
         After obtaining approval from the institutional ethical committee, 
Thanjavur Medical College,Thanjavur, the study was conducted in 100 ASA I 
or II patients, aged between 15 to 55 years undergoing elective upper limb 
surgeries under supraclavicular block. Before including the patients for the 
surgery,all patients were  explained about the procedure and written informed 
consent was taken from the patient and the patient’s attenders. Result values were 
recorded using a preset proforma. 
 
Inclusion criteria : 
o ASA CLASS I & II 
  
o Age between 15 to 55 years. 
  
o SBP → 100 – 139mm of Hg. 
  
o DBP → 60 – 89mm of Hg. 
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 vExclusion criteria : 
  
 Patients with a previous history  of hypersensitivity  to Midazolam 
        Patients with medical complications like anemia, uncontrolled diabetes 
mellitus, liver failure, renal failure,cardiovascular disorders, 
 Abnormal BT,  CT or on anticoagulant therapy. 
 Local infection 
Patient refusal 
  Neuromuscular disorders 
           Pregnancy 
           Nerve injury 
   
 Each patient was randomly allocated into one of the two groups of 50     
patients each 
 
 Control group – Group-B :Received 30 ml of Inj. bupivacaine (0.375%) 
 Study group – Group BM: Received 30 ml of mixture of  
I n j . bupivacaine (0.375%) and midazolam (2.5 mg)(Preservative free) 
 
   Materials: 
Sterile tray, sterile swab, sterile towel, sponge holding forceps 
Drugs for the block: 0.375%  bupivacaine 30 ml and midazolam 2.5 
mg(preservative free) 
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Equipments and drugs for resuscitation and conversion to general anaesthesia in 
the case of block failure were kept ready. 
 Methods : 
   Pre operative preparation: 
Patients were preoperatively assessed and ASA risk stratified. Basic 
investigations like blood grouping/typing, haemoglobin, bleeding/clotting 
time, blood sugar, renal function test, urine routine, chest x-ray, ECG were 
done. 
        All patients were premedicated with  Inj. Glycopyrrolate 45 
minutes prior to the planned procedure.Peripheral venous line was accessed  
using a 18G intravenous cannula and all patients were preloaded with 10 ml/kg 
of Ringer lactate solution just within 30 minutes before performing the 
suparaclavicular block.  Monitor was connected and baseline parameters 
namely heart rate, blood pressure, SpO2, respiratory rate were recorded.  
 
 Patient’s position- Patient was laid supine with the head 30 0 turned to the       
opposite side.The arm on the operative side is adducted, the shoulder is down 
and the elbow is fixed. A small folded towel was placed below the shoulder at 
interscapular area to make the field more prominent.  
 
  Needle size - 22 gauge, 5 cm needle 
 Anaesthetic Solution Volume – 30 ml 
71 
 
 Anatomic Landmarks- The interscalene groove and mid-point of 
clavicle,subclavian artery pulsations  were   identified 
  
Approach and Technique - Identify the interscalene groove.This is often a 
shallow dimple.Follow the groove down the root of the neck.The subclavian 
artery is palpable in 50% of the patients in this position. 
    - After aseptic preparation of area, at a point 1.5 to 2.0cm posterior and 
cephalad  to the mid point of clavicle, subclavian artery pulsations were 
felt. A skin wheel was raised with local anaesthetic just cephalo-posterior 
to the pulsations.. 
- Insert the a 22 gauge, 5 cm needle at the lowest point of the interscalene 
groove(where the skin is beginning to flatten out over the supraclavicular 
fossa),in the posterior part of the groove and posterior to the subclavian artery  
 - The plexus may be identified using either paraesthesia or muscle 
stimulation  
 - Using paraesthesia, sensation must be elicited in any area below the 
shoulder/deltoid.Best results follow paraesthesia in the hand or 
fingers.However paraesthesia limited thumb alone are associated with apoor 
block success rate. 
   - After eliciting paraesthesia,a 10ml syringe was mounted on the needle and  
after negative aspiration of blood, the study medication was  injected. 
 -  All patients were monitored for onset of sensory blockade, motor  blockade 
and   for any complications 
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Assessment Of Sensory Blockade 
The sensory scales used for assessment were 4-point scale ,Hollmen’s scale.  
       Hollmen’s scale was  used to evaluate sensory blockade: 
      Sensory block was assessed by pin prick with 23g hypodermic needle in skin 
      dermatomes C4-T2 once in every minute for initial 30 minutes and then after 
every 30 minutes. 
1-  Normal sensation of pin prick 
2-  Pinprick felt as sharp pointed but weaker compared to the area in the 
opposite limb. 
3-  Pinprick recognised as touch with blunt object. 
4-  No perception of pin prick 
Onset of sensory block was assessed as the time interval between 
administration of drug and absence of sensation to pin prick.(Hollmen’s ≥3) 
 Duration of sensory block was defined as the time elapsed between    
injection of drug and appearance of pain requiring analgesia was also 
noted.(Hollmen’s scale less than or equal to 1) 
      
      Assessment Of Motor  Blockade – 
The  scales used for assessment of motor blockade were Hollmen motor 
scale,Modified Bromage scale,Lavoie’s scale. 
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Lavoie’s criteria was used for evaluation of motor blockade: 
Grade 1- 0   – flexion and extension in both the hand and arm against resistance 
Grade 2 -33%- flexion and extension in both the hand and arm against gravity 
but not against resistance 
Grade 3- 66%- flexion and extension movements in the hand but not in the arm 
Grade 4- 100%- No movement in the entire upper limb 
Onset of motor block was assessed as the time interval between administration 
of drug and loss of flexion/extension movements in the arm.(Lavoie’s criteria 
Grade 3) 
 Duration of motor block was defined as the time elapsed between injection  
of drug and complete return of muscle power was also noted(Lavoie’s criteria 
Grade 1) 
     Sedation score described by Culebras et al 4was used to assess sedation. 
        1 – awake and alert 
  
        2 – sedated, responding to verbal stimulus. 
  
        3 – sedated, responding to mild physical stimulus. 
  
        4 – sedated, responding to moderate or severe physical stimulus. 
 
 
        5 – not arousable. 
 
Other sedation scores include Ramsay sedation score,University of Michigan 
sedation scale,verbal rating score,bispectral index score(BIS score), 
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OAA/S(Observer’s Assessment Alertness/Sedation) 
    The effect on the following parameters were observed 
1) Onset of sensory blockade 
2) Onset of motor blockade 
3) Duration of sensory blockade 
4) Duration of motor blockade 
5) Sedation score 
6) Haemodynamic variables 
7) Number of rescue analgesics given during 24 hours post-operative period. 
 
Success of the block was defined   as: 
     A) Complete: Intended surgical procedure being able to be performed with no     
sedation. 
B) Incomplete: Intended surgical procedure being able to be performed with 
minimal sedation. The patient was intraoperatively sedated only after the block 
was already classified. When required,Inj Pentazocine (0.5 mg/kg), intermittent 
doses of Inj.Propofol (0.5 mg/kg) and Inj. Ketamine (0.5 mg/kg) was given 
intravenously to supplement the anaesthesia. 
C) Failed block: Intended surgical procedure not being able to be perfomed 
under the block, and requiring conversion to general anaesthesia. 
- Heart rate, non-invasive blood pressure and O2 saturation were also  
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monitored.  
 
  - Number of rescue analgesics in 24 hours of post-operative period was       
also recorded. 
      - All patients were monitored  for 24 hours post-operatively. 
- All patients were given rescue analgesics if they complained of pain or any 
discomfort 
       Patients were watched for bradycardia, convulsions, restlessness, disorientation, 
drowsiness, nausea, vomiting and any other complications  
Statistical Tools   
The information collected regarding all the selected cases were recorded in a 
Master Chart.  
Data analysis was done with the help of computer using Epidemiological 
Information Package (EPI 2010) developed by Centre for Disease Control, Atlanta.
   Using this software range, frequencies, percentages, means, standard 
deviations, chi square and ‘p’ values were calculated. Student’s ‘t”  test was used 
to test the significance of difference between quantitative variables and Yate’s chi 
square test was used for qualitative variables. 
A ‘p’ less than 0.001 was considered to be  highly significant. 
A 'p' value less than 0.05 was considered to be significant. 
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                                   OBSERVATION AND RESULTS 
 
  
This prospective single blind randomised controlled study was done in 
100 ASAI and II of either sex aged between 15-55 years , posted for upper limb 
surgeries under supraclavicular brachial plexus block.The study was 
undertaken to evaluate the efficacy of midazolam (2.5mg) as an adjuvant to 
bupivacaine (0.375%) in comparison with plain bupivacaine (0.375%) for 
brachial plexus block by supraclavicular approach. 
 
 
 
DEMOGRAPHIC DATA 
 
 
 
Table 1 : Age-wise  Distribution of Study groups 
 
 
 
Age in 
years 
Group B Group BM t value p value Significance 
No. % No. % 
0.216 0.83 
Not 
Significant 
15-25 13 26 15 30 
26-35 16 32 15 30 
36-45 11 22 8 16 
46-55 10 20 12 24 
TOTAL 50 100 50 100 
 
Group B : Bupivacaine 
Group BM : Bupivacaine – Midazolam 
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   As shown in Table 1 the minimum age of the patient was 15 years and the 
maximum age was 55 years. The total number of persons in Group B in theage 
group 15-25 is 13 while in Group BM is 15.The total number of persons in Group 
B in the age group 26-35  is 16 while in Group BM is 15.The total number of 
persons in Group B in the age group 36-45 is 11 while in Group BM is 8.The total 
number of persons in the age group 46-55in Group B is 10 while in Group BM is 
12. Samples are age matched with p value which was found out to be 
0.83.(p>0.05),hence statistically not significant.So the age distribution between the 
two groups were comparable. 
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Table 2 : Comparison Of Group B And Group BM On The Basis Of Time For 
Onset Of Sensory Block (Min) 
 
 
Study 
 
group 
 
Onset time 
(min) 
Mean 
 
difference 
 
 
t* 
value 
 
 
p value 
 
 
Significance 
 
B 
 
19.08 1.7 
 
 
7.82 
 
 
24.13 
 
 
0.0007 
 
 
 
 
HS 
 BM 
 
11.26 1.5 
 
 
* Student’s unpaired t test 
  
HS – Highly significant(p<0.001) 
 
  
As shown in Table 2 the mean time for onset of sensory block in group 
BM was 11.26 1.53 min and in group B was 19.07 1.7 min. The statistical 
analysis by student’s unpaired ‘t’test showed that, the time for onset of 
sensory block in group BM was significantly faster when compared to group 
B (p< 0.001). 
 
 
 
Table 3 : Comparison of Group B and Group BM on the basis of time for 
onset of motor block (min) 
  
Study 
 
group 
 
Onset time 
 
(min) 
 
Mean 
 
difference 
 
 
t* value 
 
 
p value 
 
 
Significance 
 
B 
 
15.30 2.09 
 
 
5.74 
 
 
16.38 
 
 
0.0009 
 
 
HS 
 BM 
 
9.56 1.32 
 
 
* Student’s unpaired t test 
  
HS – Highly significant (p<0.001)  
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              As shown in Table 3 the mean time for onset of motor block in group BM 
was 9.56 1.32 min and in group B was 15.3 2.09 min. The statistical 
analysis by unpaired student’s ‘t’ test showed that, the time for onset of 
motor block was significantly faster when compared to group B (p< 0.001). 
 
 
 
 
 
 
 
 
 
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
20 
BUPIVACAINE 
BUPIVACAINE-MIDAZOLAM 
19.08 
11.26 
15.3 
9.56 
M
e
an
 V
al
u
e
 
Study groups 
Graph 2 : Onset Of Block 
Sensory (min) 
Motor (min) 
81 
 
Table 4 : Comparison of Group B and Group BM on the basis of Duration of 
Sensory Block (hours) 
Study 
 
group 
 
Duration of 
block (hrs) 
 
Mean 
 
difference 
 
 
t* value 
 
 
p value 
 
 
Significance 
 
B 
 
5.84 0.49 
 
 
7.96 
 
 
42.2 
 
 
 0.0003 
 
 
HS 
 BM 
 
13.81 1.23 
 
 
* Student’s unpaired t test 
  
HS – Highly significant(p<0.001) 
 
As shown in Table 4 patients of both groups were observed for 24 hours. 
Time was noted when the patient asked for rescue analgesics. The mean 
duration of sensory block in group BM was 13.81 1.23 hours and in group B 
was 5.84 0.49 hours. The statistical analysis by students unpaired ‘t’ test 
showed that the duration of sensory block in group BM was significantly 
longer when compared to group B (p < 0.001). 
 
 
Table 5 : Comparison of Group B and Group BM on the basis of Duration of 
motor block (hours) 
 
Study 
 
group 
 
Duration 
of 
 
block (hrs) 
 
Mean 
 
difference 
 
t* value 
 
 
p value 
 
 
Significance 
 
B 
 
5.13 0.45 
 
 
0.12 
 
 
1.32 
 
 
0.12 
 
 
NS 
 BM 
 
5.25 0.45 
 
 
* Student’s unpaired t test  NS – Not significant (p>0.05) 
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As shown in Table 5 the mean duration of motor block in group BM was 
5.25 0.45 hours and the group B was 5.13 0.45 hours. The statistical 
analysis by students unpaired ‘t’ test showed that the difference between 
duration of motor block in group BM and group B was not significant (p > 
0.05). 
 
 
 
0 2 4 6 8 10 12 14 
BUPIVACAINE 
BUPIVACAINE-MIDAZOLAM 
5.84 
13.81 
5.13 
5.25 
Mean Value 
S
T
U
D
Y
 
G
R
O
U
P
S
 
Graph 3 : Duration Of Block 
Motor (min) 
Sensory (min) 
83 
 
Table 6 : Comparison of Group B and Group BM on the basis of Number of 
Rescue Analgesics required in 24 hours post-op period 
 
  
 
No. of RA in 24 hours 
post-op 
 
 
BUPIVACAINE 
 
BUPIVACAINE+ 
 
MIDAZOLAM 
 
 
1 
 
 
0 
 
 
37 (74) 
  
2 
 
 
38 (76) 
 
 
13 (26) 
  
3 
 
 
12 (24) 
 
 
0 
  
 = 61.25 P= 0.0008 Highly Significant(p<0.001) 
  
Figures in the parenthesis indicate column wise percentage 
 
 
 
  
As shown in Table 6, in group BM, 74% patients required only 1 rescue 
analgesic dosage and 26% of patients required 2 rescue analgesic doses in 
post-op 24 hours. In group B 76% of patients required 2 and 24% of 
patients required 3 rescue analgesic doses in post-op 24 hours. This 
difference in number of rescue analgesic doses required by patient of both 
groups is statistically highly significant by chi-square test (2 = 61.25, p< 
0.001). 
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Table 7 : Comparison of Group B and Group BM on the basis of Sedation 
score 
 
Time of 
 
Assessment 
 
 
Scores  
 
 
Bupivacaine 
 
Bupivacaine 
 
-Midazolam 
 
X2 Value, 
 
    p value 
  
0 min 
 
1 
 
50 (100) 
 
50 (100) 
 
- 
 2 
 
0 
 
0 
 
          - 
 
5 min 
 
1 
 
50 (100) 
 
50 (100) 
 
- 
 2 
 
0 
 
0 
 
          - 
  
15 min 
 
1 
 
50 (100) 
 
40 (80) 
 
X2 = 9.0 
 2 
 
0 
 
10 (20) 
 
   p = 0.01 
  
30 min 
 
1 
 
50 (100) 
 
34 (68) 
 
X2 = 16.74 
 2 
 
0 
 
16 (32) 
 
   p  = 0.005 
  
60 min 
 
1 
 
50 (100) 
 
37 (74) 
 
X2 = 12.73 
 2 
 
0 
 
13 (26) 
 
   p = 0.009  
  
2 hrs 
 
1 
 
50 (100) 
 
50 (100) 
 
- 
 2 
 
0 
 
0 
 
          - 
  
6 hrs 
 
1 
 
50 (100) 
 
50 (100) 
 
- 
 2 
 
0 
 
0 
 
          - 
  
12 hrs 
 
1 
 
50 (100) 
 
50 (100) 
 
- 
 2 
 
0 
 
0 
 
          - 
  
24 hrs 
 
1 
 
50 (100) 
 
50 (100) 
 
- 
 2 
 
0 
 
0 
 
          - 
 
 
 
 
SEDATION  SCORES 
1 – Awake and alert 
  
2 – Sedated, responding to verbal stimulus 
  
3 – Sedated, responding to mild physical stimulus 
  
4 – Sedated, respond to moderate to severe physical stimulus 
  
5 – Not arousable       
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As shown in Table 7, in group B all patients were awake and alert and had 
sedation score of 1. In group BM, sedation corresponding to score 2 was observed 
in some patients between 15 minutes from time of injection to   60 minutes. 20% 
of patients at 15 minutes, 32% of patients  at 30 minutes and 26% of patients at 60 
minutes had sedation score of 2. None of the patients had sedation score of 3 and 
above during the study period. Statistical analysis of sedation score by chi-
square test showed that the difference in sedation score was significant (p < 
0.05) during 15, 30 and 60 minutes 
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Hemodynamic variables : 
  
Pulse rate, systolic BP, diastolic BP, O2 saturation was recorded at 0 
min, 5 min, 15 min, 30 min, 60 min, 2 hours, 6 hours, 12 hours, 24 hours. 
 
 
  
Table 8 : Comparison of Group B and Group BM on the basis of Pulse Rate 
(beats / min) 
 
Time of 
 
Assessment 
 
Mean+/- SD 
 
Mean 
 
Difference 
 
t* 
 
Value 
 
p 
 
Value 
 
Signifi 
 
cance 
 
Bupivacaine 
 
Bupivacaine-
Midazolam 
 
0 min 
 
77 6.8 
 
78 7.4 
 
1.48 
 
1.03 
 
 0.18 
 
NS 
 5 min 
 
77 6.6 
 
78 7.0 
 
1.24 
 
0.91 
 
 0.23 
 
NS 
 15 min 
 
76 7.0 
 
78 7.0 
 
1.44 
 
1.03 
 
 0.17 
 
NS 
 30 min 
 
76 6.6 
 
78 7.4 
 
1.46 
 
1.04 
 
 0.16 
 
NS 
 60 min 
 
77 6.5 
 
78 7.2 
 
1.36 
 
0.99 
 
 0.22 
 
NS 
 2 hrs 
 
77 7.0 
 
78 7.0 
 
1.1 
 
0.79 
 
 0.32 
 
NS 
 6 hrs 
 
77 6.6 
 
78 7.0 
 
1.48 
 
1.05 
 
 0.19 
 
NS 
 12 hrs 
 
76 6.0 
 
78 7.0 
 
2.04 
 
1.49 
 
 0.11 
 
NS 
 24 hrs 
 
77 7.0 
 
79 7.0 
 
1.52 
 
1.09 
 
 0.19 
 
NS 
 
 
 
 
* Student's unpaired t test 
  
NS = Not Significant   (  p value > 0.05)                                            
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As shown in Table 8, in group B, the mean pulse rate ranged from 76 6.0 to 
77 7.0 beats/ min.    In group BM, the mean pulse rate ranged from 78 7.0 to 
79 7.0 beats / min. The statistical analysis by student’s unpaired ‘t’ test showed 
that there was no significant difference in pulse rate between the two groups (p > 
0.05). 
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Table 9 : Comparison of Systolic blood pressure (mm of Hg) in Group B and 
Group BM 
 
 
 
 
Time of 
Assessment 
 
Mean+/- SD 
 
 
 
Mean 
Difference 
 
 
t* 
Value 
 
 
p 
Value 
 
 
Signifi 
cance 
 
 
Bupivacaine 
 
Bupivacaine-
Midazolam 
 0 min 
 
117 10.45 
 
117 10.53 
 
0.76 
 
0.36 
 
 0.62 
 
NS 
 5 min 
 
118 10.37 
 
117 10.88 
 
0.1 
 
0.047 
 
 0.92 
 
NS 
 15 min 
 
118 010.01 
 
118 10.84 
 
0.08 
 
0.038 
 
 0.94 
 
NS 
 30 min 
 
118 10.38 
 
118 11.01 
 
0.12 
 
0.056 
 
 0.91 
 
NS 
 60 min 
 
118 9.47 
 
117 10.86 
 
0.02 
 
0.01 
 
 0.99 
 
NS 
 2 hrs 
 
117 10.04 
 
118 10.99 
 
0.7 
 
0.33 
 
 0.64 
 
NS 
 6 hrs 
 
117 10.01 
 
118 11.19 
 
0.48 
 
0.22 
 
 0.83 
 
NS 
 12 hrs 
 
117 9.96 
 
118 11.10 
 
0.68 
 
0.32 
 
 0.65 
 
NS 
 24 hrs 
 
117 9.85 
 
118 11.07 
 
1.04 
 
0.49 
 
 0.52 
 
NS 
 
 
 
 
* Student's unpaired t test 
  
 
NS = Not Significant (p >0.05) 
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As shown in Table 9, in group B, the mean systolic blood pressure 
ranged from 117 9.85 to 118 10.38 mm of Hg. In group BM, the mean 
systolic blood pressure ranged from 117  10.53 to 118 11.19 mm of Hg. 
The statistical analysis by unpaired student’s ‘t’ test showed that there was no 
significant difference in systolic blood pressure between the two groups (p > 
0.05). 
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Table 10 : Comparison of Diastolic blood pressure (mm of Hg) in Group B and 
Group BM 
 
 
 
 
Time of 
Assessment 
 
Mean+/- SD 
 
 
Mean 
Differen
ce 
 
 
t* 
Value 
 
 
p Value 
 
 
Signifi 
cance 
 
 
Bupivacaine 
 
Bupivacaine-
Midazolam 
 
0 min 
 
76 7.72 
 
77 6.8 
 
0.38 
 
0.26 
 
 0.81 
 
NS 
 5 min 
 
76 7.52 
 
77 6.74 
 
1.02 
 
0.71 
 
 0.38 
 
NS 
 15 min 
 
76 7.07 
 
77 6.72 
 
1.14 
 
0.82 
 
 0.31 
 
NS 
 30 min 
 
77 7.10 
 
77 6.85 
 
0.38 
 
0.27 
 
 0.79 
 
NS 
 60 min 
 
76 7.03 
 
77 6.66 
 
0.74 
 
0.54 
 
 0.52 
 
NS 
 2 hrs 
 
76 7.06 
 
77 6.82 
 
0.48 
 
0.34 
 
 0.72 
 
NS 
 6 hrs 
 
76 7.15 
 
77 6.73 
 
0.52 
 
0.37 
 
 0.75 
 
NS 
 12 hrs 
 
76 6.9 
 
77 6.92 
 
0.52 
 
0.37 
 
 0.75 
 
NS 
 24 hrs 
 
76 6.9 
 
77 6.67 
 
0.5 
 
0.36 
 
 0.74 
 
NS 
  
 
 
 
* Student's unpaired t test 
  
 
  NS = Not Significant (P>0.05) 
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           As shown in Table 10, in group B, the mean diastolic blood pressure ranged 
from 76 6.9 to 77 7.1mm of Hg. In group BM, the mean diastolic blood 
pressure ranged from 77 6.6 to 77 6.9 mm of Hg. The statistical analysis by 
student’s unpaired ‘t’ test showed that there was no significant difference in 
diastolic blood pressure between the two groups (p > 0.05). 
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Table 11 : Comparison of  Oxygen saturation (%) of Group B and Group BM 
 
 
  
 
Time of 
Assessment 
 
Mean+/- SD 
 
 
 
t* 
Value 
 
 
   p 
Value 
 
 
Significance 
 
 
Bupivacaine 
 
Bupivacaine
-Midazolam 
 
0 min 
 
99 0.56 
 
99 0.49 
 
0.01 
 
0.99 
 
NS 
 
5 min 
 
99 0.47 
 
98 0.50 
 
1.8 
 
 0.12 
 
NS 
 
15 min 
 
99 0.49 
 
99 0.50 
 
0.39 
 
 0.75 
 
NS 
 
30 min 
 
98 0.54 
 
98 0.50 
 
2.09 
 
 0.10 
 
NS 
 
60 min 
 
99 0.50 
 
98 0.50 
 
0.19 
 
 0.88 
 
NS 
 
2 hrs 
 
99 0.48 
 
99 0.47 
 
0.20 
 
 0.85 
 
NS 
 
6 hrs 
 
99 0.49 
 
99 0.47 
 
2.45 
 
 0.09 
 
NS 
 
12 hrs 
 
99 0.57 
 
99 0.46 
 
2.09 
 
 0.05 
 
NS 
 
24 hrs 
 
99 0.48 
 
99 0.46 
 
3.58 
 
 0.05 
 
NS 
 
 
 
 
* Student's unpaired t test 
  
 
 NS = Not Significant (p value >0.05)  
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As shown in Table 11, in group B, the mean O2 saturation ranged from 
98 0.5% to 99 0.57%. In group BM, the mean O2 saturation ranged from 
98 0.5%. The statistical analysis by students unpaired ‘t’ test showed that 
there was no significant difference in O2 saturation between the two groups 
(p > 0.05). 
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96 
 
  
 
DISCUSSION 
  
 
Brachial plexus block provides postoperative analgesia of short 
duration1, even when a long-acting local anaesthetic like Bupivacaine is used 
alone. Various adjuvant drugs like Neostigmine1 ,Opioids2, Hyaluronidase3and 
Clonidine4 have been evaluated in conjunction with local anaesthetics to 
prolong the period of analgesia , but they were found to be either ineffective 
or to produce an unacceptably high incidence of adverse effects.4  
 
This  was a prospective , randomized  single blinded study carried out at  
Thanjavur Medical College Hospital, Thanjavur.100 ASA 1 and ASA II 
patients undergoing elective upper limb surgeries  were included in the study. 
Patients were divided into 2 groups of 50 each . ( Group B and Group  
BM.)Group B received supraclavicular brachial plexus block with 30 ml of 
0.375% plain bupivacaine . Group BM received supraclavicular Brachial 
plexus block with 30 ml of 0.375% bupivacaine with preservative  free 
midazolam 2.5mg. Parameters observed included onset time of sensory block , 
onset time of motor block , duration of sensory block , duration of motor block 
, duration of analgesia,number of rescue analgesics needed in the 24 hours 
post-operative period,haemodynamic changes and sedation score 
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   Patient characteristics across the groups 
       The patients in our study groups did not vary much with respect to  age . 
The p value was 0.83 for age-wise distribution among the groups (p >0.05),and 
hence not significant. The mean age group for bupivacaine group in our study 
was 33.4+10.81 and in bupivacaine-midazolam group was 32.9+12.32. 
   
  Nasreen et al 38 also found that there was no significant difference between 
the age groups.The mean age for bupivacaine group was 32.5+2.47 while in 
bupivacaine-midazolam was 33.1+1.46 .The p value was 0.3010 for age-wise 
distribution among the groups (p >0.05). 
 
In another study by Koj Jarbo et al 28 ,the mean age for group B(bupivacaine) 
is 33.2+9.29 and the mean age group for BM(bupivacaine-midazolam) was 
33.65+9.34, the p value for age-wise distribution was >0.05,hence not 
significant.This was in concordance with our study in which mean age did not 
vary much among the groups. 
  
   Changes in the perioperative cardiovascular parameters 
There were  no significant differences between the study groups with 
respect to pattern of changes in pulse  rate, systolic blood pressure, diastolic 
blood pressure  perioperatively .The pulse rate was recorded at 0 min,5 min,15 
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min, 30 min ,60 min,2 hours, 6 hours,12 hours and 24 hours.The p values 
measured during these intervals were found to be not significant(p>0.05).The 
diastolic and systolic blood pressure was recorded 0 min,5 min,15 min, 30 min,  
60 min,2 hours, 6 hours,12 hours and 24 hours.The p values recorded during 
the intervals were found to be not significant.(p>0.05).Likewise,oxygen 
saturation(%) was also recorded during the same time intervals,which was not 
significant(p value >0.05)  
    
   Koj Jarbo et al28
 
 in their study, concluded that heart rate,systolic blood 
pressure,diastolic blood pressure,mean arterial blood pressure,oxygen 
saturation were comparable between the study groups(plain bupivacaine and 
bupivacaine-midazolam) and did not change significantly in the intra or 
postoperative period.
 
 
       
    Nasreen et al38
 
 in their study concluded that the hemodynamic variables 
were comparable between the age groups and did not change significantly in 
the intraoperative and post operative period. 
 
In a study conducted by Shaikh et al34, they found no statistically 
significant hemodynamic changes when midazolam was added to bupivacaine 
in supraclavicular brachial plexus block (p>0.05).In another study conducted 
by Batra et al,
7
they found no statistical difference in hemodynamic parameters 
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when preservative free midazolam was added to intrathecal 
bupivacaine(p>0.05) . 
These findings correlates with our study in which haemodynamic 
variables were comparable between the study groups. 
 
Onset time of Sensory block 
 
 In our study, we found out that the onset of sensory blockade 
was significantly faster in patients who received a combination of 
midazolam and bupivacaine. The mean value for the onset of sensory 
block for group BM was 11.26 1.5 min; while in group B was 19.08  1.7 
min.The p value was found to be 0.0007 ,which was found to be statistically  
significant  (p<0.05). 
   
These values were in conjunction with that of the study conducted by 
Koj Jarbo et   al 28
  
 in which they found out that the mean value for the onset 
of sensory block  was significantly faster in group BM (12±2.9 mins) when 
compared to group B (20+3.8),(p <0.05),which was statistically significant. 
Hence, the authors concluded  that preservative free midazolam 2.5mg  added 
to bupivacaine  has an advantage of early onset of  sensory blockade when 
compared to plain bupivacaine for supraclavicular brachial plexus block. This 
could be due to the local anaesthetic property of Midazolam and its 
synergistic action with that of local anaesthetics.14  
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       In another study by Nasreen Laiq et al 38, the onset of sensory block 
appeared earlier in group B(bupivacaine –midazolam group) than in group 
A(plain bupivacaine group) . In group B, the mean value for onset of sensory 
block occurred in 14 ± 3.1 minutes compared to 22 ± 3.5 minutes in group 
A.The p value was found out  to be less than 0.001,hence statistically 
significant. 
 
         These values were in concordance with our study in which mean 
onset time of sensory block was faster in bupivacaine-preservative free 
midazolam group compared to plain bupivacaine group. 
 
   In a study conducted by Shaikh et al
 34 ,they found no statistical 
difference in the onset of sensory block when midazolam was added to 
bupivacaine.The mean value for  onset of sensory block in plain 
bupivacaine group was 8.36+3.58mins while in bupivacaine-midazolam 
was 8.52+4.18.They found the p value to be more than 0.05,hence 
statistically not significant.They concluded that the onset of sensory 
blockade was same for both the groups. 
 
    This was in contrast with our study that the onset of sensory 
blockade was earlier in bupivacaine-midazolam mixture. 
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       Onset of Motor Block 
             In our study, we found out that the onset of motor  blockade 
was significantly faster in patients who received a combination of 
preservative free midazolam and bupivacaine. Onset of motor block for group 
BM was  9.56 1.32 min and in group B was 15.30 2.09 min, which was 
statistically  significant(p = 0.0009). 
  These values were in conjunction with that of the study of Koj Jarbo 
et   al 28
  
 in which they found out that the onset of   motor block  was 
significantly faster in group BM (9.2 ± 2.38 mins) when compared to group 
B (17.1+3.83),which was statistically significant(p < 0.05).  
    Nasreen Laiq et al 38 also found that the onset of motor block appeared 
earlier in group B(bupivacaine –midazolam group) than in group A(plain 
bupivacaine group) .In group B, the onset of motor block occurred in 10.5+ 
2.40 minutes compared to 18.5 ± 3.50 minutes in group A.The p value was 
found to be less than 0.001,hence statistically significant.. 
 
Shaikh et al34  conducted a study in which they found that the onset of 
motor blockade was 9.96+5.69 mins in plain bupivacaine group compared to 
7.92 + 5.68 mins. The p value was found to be more than 0.05, hence 
statistically not significant. 
This was in contrast with our study in which there is significant 
difference between the onset of motor blockade among the study groups. 
The onset of motor block was found to be faster than the onset of 
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sensory block in both groups. Winnie et al.11, observed this also, and 
attributed this to the somatotrophic arrangement of fibres in a nerve bundle 
at the level of the trunks in which motor fibres are located more peripherally 
than sensory fibres. Hence, a local anaesthetic injected perineurally will 
begin to  block motor fibres before it arrives at the centrally located sensory 
fibres. 
Midazolam a water soluble benzodiazepine is known to 
produce antinociception and to enhance the effect of local anaesthetic 
when administered intrathecally and epidurally. Midazolam produces this 
effect by its action GABA receptors. GABA receptors are also found in 
peripheral nerves
5
 
     
      Duration of Sensory block 
                   In our study the mean duration of sensory block in group BM 
was 13.81 1.23 hours and in group B was 5.84 0.49 hours.The mean 
duration of sensory block was significantly higher (P = 0.0003) in group BM 
(bupivacaine-midazolam) than in group B(bupivacaine). 
 These values were   comparable  with the  study  conducted by Koj Jarbo et  
al 2 8 ,Nasreen et  al 3 8  and Shaikh et  al 3 4 . 
   In the study conducted by Koj Jarbo et  al  2 8the duration of 
sensory block was 7+4.32 hours for BM group(bupivacaine -
midazolam) compared to group B which was 5.95 +1.4 hours.The 
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p value was found to be less than 0.05,hence statistically 
significant.  They concluded that midazolam(0.05mg/kg) added to 
bupivacaine (0.5%) hastened the onset of sensory and motor block, and  
prolonged sensory blockade in brachial plexus block,without producing any 
adverse effects.  
 
       Nasreen et al38
  
conducted a study in which the duration of sensory 
blockade was 9.30+4.30 hours compared to 6.20+1.80 hours  plain 
bupivacaine.The p value  was found out to be 0.002,which was 
significant(p<0.05). 
 
Shaikh et al34 
 
 conducted a study in which they found that the mean duration 
of sensory blockade was 502.24+52.68 mins in plain bupivacaine group 
compared to 805.04 + 175.75 mins. The p value was found to be less than 
0.001, hence statistically significant.They concluded that addition of 
midazolam to bupivacaine in supraclavicular block prolonged sensory blockade 
without any adverse effects. 
 
 
      Duration of Motor Blockade 
 
 
      In our study, the mean duration of motor block in group BM was 
5.25 0.45 hours and the group B was 5.13 0.45 hours.This result was not 
found to be statistically significant(p = 0.12)These values were   comparable   
with the  study  conducted by Koj Jarbo et al28 
 
in which they found out that the 
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mean duration of motor blockade in group BM was 5.65  3.32 hours while in 
group B was 5.1hours.This  difference was statistiscally not significant(p 
value more than 0.05). 
     Nasreen Laiq38 also found in their study that  the duration of motor 
blockade was significantly prolonged in Group bupivacaine-
midazolam(7.65+3.2 hours) when compared to Group bupivacaine (5.20+2.10 
hours)alone,which was found to be statiscally significant(p=0.0024). 
      In another study conducted by Shaikh  et al34,there was statistically 
significant prolongation of motor block in group BM than in group B.The 
duration of motor blockade was 450.48+48 mins in group B when compared to 
group BM which was 608.96+157.75 mins and this difference was statistically 
significant(p<0.001). 
 
Our results showed that sensory block tended to last longer as 
compared to motor block which agrees with the observation by  de Jong et 
al42. These authors explained that large fibres require a higher concentration 
of local anaesthetic than small fibres. The minimal effective concentration 
of local anaesthetic for large (motor) fibres is greater than for small 
(sensory) fibres. Thus, motor function return before pain perception and 
duration of motor block is shorter than the sensory block18.  However in our 
study duration of motor blocks were not different between the groups. 
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     Duration of Analgesia  
The mean time from onset of block to request of analgesics was taken 
as total duration of analgesia . The duration of analgesia was 13.81±1.23 hours 
with bupivacaine-midazolam group ( Group BM) and 5.84±.0.49 hours with 
bupivacaine group (Group B ) in our study .  
 
The duration of analgesia was longer in bupivaine-midazolam group 
compared with bupivacaine group ,which was statistically 
significant.(p=0.0003),[p value less than 0.05]. 
 
 Our study correlates with the study conducted by Gulec et al32,Shaikh 
et al34,Nasreen et al38 , Nishiyama et al23 ,Batra et al and Trivedi et al43. 
Gulec et al.32, found that caudal injection of plain bupivacaine and 
midazolam combination provides a prolonged postoperative analgesia 
when compared to bupivacaine – morphine combination. The durations 
of analgesia were 21.15+ 1.2 hrs in bupivacaine-midazolam group,14.50+ 
1.6 hrs in bupivacaine-morphine group and 8.15+ 1.3 hrs in bupivacaine 
group.The difference between plain bupivacaine and bupivacaine-midazolam 
group was statistically significant(P<0.001),bupivacaine-midazolam and 
bupivacaine-morphine group was  also significant(P<0.01). 
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This study supports the fact that midazolam prolongs post-operative analgesia 
when used along with bupivacaine. 
    
Shaikh et al34 
 
 conducted a study in which they found that the mean duration 
of analgeisa was 502.24+52.68 mins in plain bupivacaine group compared to 
805.04 + 175.75 mins. The p value was found to be less than 0.001, hence 
statistically significant.They concluded that addition of midazolam to 
bupivacaine in supraclavicular block prolonged post-operative analgesic effects 
without any adverse effects. 
               
        In another study by Nasreen et al38 
 
,they found out that lower pain 
scores were observed in group B(bupivacaine-midazolam group)compared to 
group A(plain bupivacaine) for 24 hours postoperatively (p < 0.001).The  
duration of analgesia was 9.30+ 4.30 hours compared to 6.20+1.80 hours  plain 
bupivacaine.The p value  was found out to be 0.002,which was statistically 
significant(p<0.05). 
 
                      
        Nishiyama et al.,23 in their study, added midazolam to a continuous 
epidural infusion of Bupivacaine and they observed improved  analgesia with 
bupivacaine-midazolam mixture . Time to first analgesic administration were 
longer (P < 0.001) in the bupivacaine-midazolam group than in the other  
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groups.This fact supports  that midazolam prolongs analgesic effects of 
bupivacaine.  
   
  Batra et al.20
 
used bupivacaine with midazolam intrathecally and found a 
significantly prolonged analgesia when compared to bupivacaine alone. A 
significantly higher Visual Analogue score (P < 0.05) was seen in group B 
(bupivacaine alone) when compared to group BM (bupivacaine-midazolam) 
group.   
  
Trivedi V et al43 conducted a study to compare the effects of midazolam and 
clonidine added to bupivacaine and they found out that clonidine provides better 
post operative analgesia when compared with midazolam. 
 
   Number of Rescue Analgesics used 
 
 
In our study, i n  group BM, 74% patients required only 1 rescue analgesic 
dosage and 26% of patients required 2 rescue analgesic doses in post-op 24 
hours. In group B 76% of patients required 2 and 24% of patients required 3 
rescue analgesic doses in post-op 24 hours. This difference in number of 
rescue  analgesic doses required by patient of both groups was statistically 
highly significant by chi-square test (2 = 61.25, p< 0.001).The number of 
patients who required rescue analgesia and the mean number of supplemental 
analgesia were less in bupivacaine-midazolam group  
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       Our  study correlates with the study by Jarbo et al28
  
in which they found 
out the number of rescue analgesic doses was higher (n=58) in plain bupivacaine 
group when compared to bupivacaine-midazolam group(n=8),which was 
significant(p<0.05). 
  In another study by Nasreen et al38
 
, almost all patients in plain bupivacaine 
group required rescue analgesia, while only 5 patients (20%) of midazolam-
bupivacaine group required rescue analgesics  in order to maintain analgesia in 
the first 24 hours(p <0.001),which was  found to be significant.These values 
were in concordance with our study. 
              Similar observation was made in the above mentioned study by Koj 
Jarbo et al 28.  
         
              These values were in concordance with Naguib et al 29
   
in which they 
found out that  the time of first analgesic administration were longer (P < 
0.001) in bupivacaine-midazolam group when compared  to plain bupivacaine 
group. Further, the bupivacaine-midazolam group received fewer (P < 0.05) 
doses of rescue analgesics than plain bupivacaine group.They concluded that 
caudal injection of bupivacaine-midazolam reduced the requirement of rescue 
analgesics. 
 
         In another study conducted by A.Kharbasfrushan et al40, The average time 
until the first dose of additional analgesic was 142.18±55.19 min in the 
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BNS(bupivacaine-normal saline) vs 178.06±77.33 min in the BM(bupivacaine-
midazolam) group(p value <0.05). They concluded that combination of 
bupivacaine (10 mg) plus intrathecal midazolam (2 mg) was an effective 
anesthetic technique to provide improvement in pain. 
      The prolonged analgesia in Group BM could be due to the action of 
Midazolam on GABA-A receptors
19
 present in the brachial plexus and thus 
producing antinociception 
 
 
       Sedation Score 
    We studied Midazolam at a dose of 2.5 mg, as others have used the  
same dosage in central neuraxial block without any significant adverse effects. 
In our study, sedation scores were higher in patients in Group BM compared 
to Group B, 15 minutes to 60 minutes from the time of injection of drug. 
 
 In our study, in group B all patients were awake and alert and had 
sedation score of 1. In group BM, sedation corresponding to score 2 was 
observed in some patients between 15 minutes from time of injection to 60 
minutes. 20% of patients at 15 minutes, 32% of patients  at 30 minutes and 
26% of patients at 60 minutes had sedation score of 2. None of the patients 
had sedation score of 3 and above during the study period. Statistical 
analysis of sedation score by chi-square test showed that the difference in 
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sedation score was significant (p < 0.05) during 15, 30 and 60 minutes. 
 
 Our study correlates with the studies conducted by Jarbo et al28, Shaikh et 
al34 ,Nasreen et al38 ,Sibel Baris et al39, Kharbasfrushan et al40 
 
Similar observations  were  made in the  study by Shaikh  et  a l 3 4 . In  
thei r  s tudy,group B pat ients  were  a l l  awake(score  1)whi le 
group BM patients  had a  sedat ion score  of  2  during the  f i rs t  60 
mins .  
 
In  another  s tudy by Jarbo e t  a l 2 8 , they found out  that  11 
pat ients  had a  sedat ion  score  of 2  between 10 minutes  to 20 
minutes  from the time of injection. 
 
This could be due to partial vascular uptake of Midazolam, and its 
transport to the central nervous system where it acts and produces sedation. 
Adding midazolam not only provides prolonged post-operative 
analgesia but also sedation as in a study described by Nishiyama et al 24
 
                                     
In another study conducted by Nasreen et al38, perioperatively sedation 
scores were higher in group B compared to group A (p < 0.001) as patients in 
group A were all awake (score 1) throughout the intraoperative period while in 
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group B, 6 patients at 10 minutes, 10 patients at 20 minutes and 15 patients at 
30 minutes were sedated and responded to verbal stimulation (score 2). The 
highest sedation score was 2 in group B and no patient had sedation score of 3 
or more that required assistance for airway maintenance.This was in 
accordance with our study. 
 
 In a study conducted by A.Kharbasfrushan et al40
 
sedation was present 
in the group that received bupivacaine plus intrathecal midazolam compared 
with those who received intrathecal bupivacaine plus normal saline when given 
(p<0.05),hence statistically significant. 
 
In another study conducted by Sibel Baris et al39, sedation score was 
higher in the BM(bupivacaine-midazolam) group at 60 and 90 minutes 
postoperatively than the other groups(plain bupivacaine and bupivacaine-
fentanyl).The result was statistically significant(p value <0.05) 
 
The limited duration of sedation could be explained by the fact that 
midazolam is highly lipophilic and diffuses faster into the blood vessels, by 
its rapid clearance (6-11 mL.kg-1.min-1) and short half-life (1.7-2.6 hr)44 
.Though  mean sedation score in group BM was higher as compared to 
group B (P < 0.05), we did not observe clinically significant sedation in 
patients in group BM. No patient experienced airway compromise or required 
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airway assistance. This mild sedation was actually desirable during that 
period.This values are comparable with the Shaikh et al
37 
and with that of Koj 
Jarbo et al28
 
 
In a study, Gupta et al41, the median effective volume [95% 
confidence interval (CI)] for 0.25%, 0.375%, and 0.5% bupivacaine for 
supraclavicular block was 26.8 (18.6-38.4), 18.1 (12.1-26.0), and 12.0 (8.4-
17.3) ml, respectively. The median effective dose(ED50) (95% CI) for 0.25%, 
0.375%, and 0.5% bupivacaine was 66.9 (46.6-96.0), 68.0 (47.4-97.6), and 
60.1 (41.8-86.3) mg, respectively. The difference in the ED₅₀ dose between the 
three concentrations was not statistically significant. This study demonstrated 
that the ED₅₀ dose of bupivacaine for supraclavicular block was not dependent 
on the concentration.In our study, 0.375% of 30 ml bupivacaine was used 
unlike that of the study of Koj Jarbo et al28 ,Shaikh et al 34 and Nasreen et 
al38.But the the study given above proved the fact that success rate of block did 
not depend upon the concentration. 
   
   Mamoun al Basheer et al 45 also used 0.375% of 30 ml of bupivacaine for 
brachial plexus block in 288 patients undergoing vascular access surgeries for 
renal dialysis. All patients had an adequate block with no conversions to 
general anesthesia or cancellation of the procedure. A successful block was 
achieved in 232 (80.6%) patients while a partially successful block was 
113 
 
achieved in 56 (19.4%) patients. The median time for onset of the block was 10 
(5-20) minutes for motor block and 15 (10-35) minutes for sensory block. The 
mean duration of the block was 5.6 (2.2-48.0) hours. Prolonged blocks beyond 
24 hours occurred in 5 patients (48 hours in 1 patient, 36 hours in 1 patient, and 
24 hours in 3 patients). No clinically detectable pneumothorax or drug toxicity 
occurred. No peri-operative mortality was reported during the study period.In 
this study, they have used   0.375% of bupivacaine and  they found out equally 
good success rate when compared to 0.5% bupivacaine.This result was in 
concordance with our study. 
   
Walter Pinto et al46 also used 0.375% bupivacaine for cervical plexus 
block for carotid endarterectomy. The objective of this study was to compare the 
analgesic effects of 150 mcgs clonidine added with bupivacaine to those of 
bupivacaine in cervical plexus block.They conducted the study in 30 patients 
undergoing carotid endarterectomy. They concluded that addition of 150 μg of 
clonidine and bupivacaine in cervical plexus block for carotid endarterectomy 
did not significantly improve the analgesic effects evaluated by pain score, time 
until the first rescue analgesics. This study also supported the fact that  0.375% 
of bupivacaine provided equally good success rate when compared to 0.5% 
bupivacaine.This result correlated with that of our study.  
                
                Jean J et al47 compared the effects of clonidine and epinephrine added 
0.25% of 40 ml to 50 ml of bupivacaine in supraclavicular brachial plexus 
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block. In this study,60 ASA I and II patients were randomly allocated into 2 
groups  of 30 each.Group I receiving clonidine 150 mcgs and group II receiving 
epinephrine 200 mcgs.They concluded that block produced by clonidine was 
superior when compared to block produced by epinephrine(p<0.001).This study 
also demonstrated the fact that mean effective dose of bupivacaine needed for 
supraclavicular brachial plexus block did not depend upon the concentration.o 
major side-effects were recorded. 
We conclude that the injection of clonidine 
 
       In conclusion, “preserva t ive  f ree  midazolam 2.5 mg when added to 
30mL of In j .  bupivacaine 0.375% for supraclavicular brachial plexus block, 
speeds the onset of sensory and motor blocks (P < 0.05). This combination 
produced prolonged analgesia  and reduced  requirements for rescue analgesics. 
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SUMMARY 
         
              We conducted a prospective randomised single blinded study “A 
clinical comparison between bupivacaine- midazolam(preservative free.) 
combination and bupivacaine (plain) in brachial plexus block by 
supraclavicular approach” was conducted in 100 patients ASA grade I and II 
admitted to Thanjavur Medical College hospital,Thanjavur ,for upper limb 
surgeries .Patients of both sexes, ranging between 15-55 years of age,were 
included. 
              Our aim was to compare the efficacy of adding 2.5 mg of 
midazolam(preservative free) to 0.375% Inj.bupivacaine with plain 
Inj.bupivacaine(0.375%) for onset and duration of motor and sensory 
blockade,haemodynamic stability,sedation score,requirements of rescue 
analgesics in the immediate 24 hours post-operative period. 
  
The patients were randomly divided into 2 groups : 
  
Group BM – Received 30 ml of 0.375% Inj.bupivacaine + 2.5 mg  of 
Inj.midazolam(preservative free) 
Group B – Received 30 ml of 0.375% Inj. bupivacaine only. 
 
 
The following parameters were recorded and compared. 
 
 
1) Onset of sensory and motor block 
  
2) Duration of sensory and motor block 
  
3) Number of rescue analgesics in the immediate  24 hours post-operatively 
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4) Sedation score 
  
5) Changes in heart rate, systolic and diastolic blood pressure and O2 
saturation were noted in both groups. 
 
Data  collected were analysed with the help of computer using 
Epidemiological Information package (2008). Using this software range, 
frequencies, percentages, means, standard deviations, chi square and ‘p’ values 
were calculated. Student’s ‘t’ test was used to text the significance of difference 
between quantitative variables and Yate’s test for qualitative variables. A ‘p’ value 
less than 0.05 is taken to denote significant result. 
 
We found out that: 
 
1. Addition of midazolam to local anesthetic solution (Bupivacaine) shows 
early onset of sensory blockade compared to Bupivacaine alone. 
2. Addition of midazolam to Bupivacaine shows early onset of motor  
blockade compared to Bupivacaine alone. 
3. Addition of midazolam to local anaesthetic solution significantly prolongs 
the duration of  analgesia  compared to Bupivacaine alone. 
4. Addition of midazolam to Bupivacaine increases the duration of sensory 
blockade  compared to Bupivacaine alone. 
5. Addition of midazolam to Bupivacaine does not prolong motor blockade 
when compared to Bupivacaine alone. 
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6. Number of rescue analgesics used were less in Bupivacaine-Midazolam 
group when compared to Bupivacaine(alone) group 
7. In midazolam group intra operative sedation is well observed without    
compromising respiratory function or any need of airway assistance. 
8. Both groups were comparable with regard to pulse rate, systolic 
blood pressure, diastolic blood pressure and O2 saturation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 
120 
 
 
 
CONCLUSION 
  
           From our study, we conclude that, the addition of Midazolam        
(2.5 mg) as an adjuvant to bupivacaine (0.375%) when compared to plain 
bupivacaine(0.375%) resulted in : 
  
i) Rapid onset of sensory block and motor block. 
 
  
ii) Prolonged duration of sensory block. 
 
iii) Reduced number of rescue analgesics in the post-operative period of 24 hours. 
 
iv) Patients were hemodynamically stable. 
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Annexures
 
 
ANENXURE I 
  
PROFORMA 
  
Name : I.P. No. : 
  
Age : Hospital : 
  
Sex : Date : 
  
PREOPERATIVE OBSERVATIONS : 
 
 
General physical examination : 
  
Pulse rate :----------------bpm 
   
B.P.  :----------------mm of Hg 
    
R.R  :----------------cycles/min 
 
 
Systemic examination : 
  
C.V.S :  
  
R.S. : 
  
Others : 
  
Investigations : 
  
Hb% : F.B.S. / R.B.S. : ECG : 
  
Blood urea : S.Creat : Urine : 
 
 
Preoperative diagnosis : 
  
Proposed surgery : 
  
Premedication : Inj. Ranitidine and inj. Ondansetron 
  
ASA grade : 
  
Anaesthetic technique : Supraclavicular approach to brachial plexus block
             
 
STUDY PROTOCOL :  
  
30ml of 0.375% bupivacaine with midazolam (0.05 mg/kg) or 30ml of 
0.375% bupivacaine alone. 
  
Time of injection : 
  
Time of onset of motor block 
  
Time to onset of sensory block 
              : ________ min 
  
              : ________ min 
  
MONITORING : 
 
 
 
 
Pulse rate 
 
SPB 
 
mm of Hg 
 
DBP 
 
mm of Hg 
 
 
SpO2 % 
 
Sedation 
 
score 
 
0 min 
 
     
5 min 
 
     
15 min 
 
     
30 min 
 
     
60 min 
 
     
2 hrs 
 
     
6 hrs 
 
     
12 hrs 
 
     
24 hrs 
 
     
 
 
 
Duration of motor blockade : __________ hrs. 
  
Duration of sensory blockade : ___________ hrs. 
  
No. of rescue analgesics in post-op 24 hrs. __________ hrs 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                         ANNEXURE -II 
                   MASTER CHART 
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
BUPIVACAINE GROUP 
  
Sl. 
No. 
 
 
Patient 
Name 
 
 
IP. No. 
 
 
Age 
(yrs) 
 
Onset of Block 
 
Duration of 
block 
 
 Sedation score 
 
Pulse Rate (beats/min) 
 
Systolic BP (mm of Hg) 
 
Diastolic BP (mmg Hg) 
 
O2 Saturation (%) 
 Sensory 
(min) 
 
Motor 
(min) 
 
Sensory 
(min) 
 
Motor 
(min) 
 
No. of RA in 
24 hours 
post-op 
 
0 
min 
 
5 
min 
 
15 
min 
 
30 
min 
 
60 
min 
 
2 
hrs 
 
6 
hrs 
 
12 
hrs 
 
24 
hrs 
 
0 
min 
 
5 
min 
 
15 
min 
 
30 
min 
 
60 
min 
 
2 
hrs 
 
6 
hrs 
 
12 
hrs 
 
24 
hrs 
 
0 
min 
 
5 
min 
 
15 
min 
 
30 
min 
 
60 
min 
 
2 
hrs 
 
6 
hrs 
 
12 
hrs 
 
24 
hrs 
 
0 
min 
 
5 
min 
 
15 
min 
 
30 
min 
 
60 
min 
 
2 
hrs 
 
6 
hrs 
 
12 
hrs 
 
24 
hrs 
 
0 
min 
 
5 
min 
 
15 
min 
 
30 
min 
 
60 
min 
 
2 
hrs 
 
6 
hrs 
 
12 
hrs 
 
24 
hrs 
 1 
 
Ranjithkumar 
 
26542 
 
21 
 
19 
 
16 
 
5.4 
 
4.6 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
74 
 
76 
 
75 
 
74 
 
72 
 
74 
 
74 
 
73 
 
75 
 
110
 
110
 
110 
 
108 
 
110 
 
108
 
112
 
110
 
110
 
71 
 
72 
 
71 
 
70 
 
71 
 
72 
 
72 
 
70 
 
71 
 
99 
 
99 
 
98 
 
99 
 
98 
 
99 
 
99 
 
99 
 
98 
 2 
 
Valarmathy 
 
26192 
 
48 
 
20 
 
14 
 
5.8 
 
4.8 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
78 
 
78 
 
79 
 
77 
 
72 
 
77 
 
76 
 
77 
 
77 
 
122
 
120
 
122 
 
124 
 
120 
 
120
 
120
 
122
 
120
 
81 
 
80 
 
81 
 
82 
 
81 
 
80 
 
82 
 
81 
 
82 
 
99 
 
99 
 
98 
 
98 
 
99 
 
99 
 
99 
 
99 
 
99 
 3 
 
Rajesh 
 
26802 
 
28 
 
18 
 
16 
 
6.7 
 
5.8 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
88 
 
86 
 
87 
 
87 
 
87 
 
87 
 
88 
 
86 
 
88 
 
104
 
106
 
104 
 
104 
 
106 
 
104
 
102
 
104
 
104
 
68 
 
69 
 
68 
 
70 
 
68 
 
70 
 
71 
 
69 
 
70 
 
99 
 
99 
 
98 
 
98 
 
98 
 
98 
 
99 
 
99 
 
99 
 4 
 
Muthusamy 
 
31672 
 
53 
 
21 
 
18 
 
6.1 
 
5.7 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
81 
 
80 
 
80 
 
80 
 
79 
 
81 
 
81 
 
80 
 
80 
 
112
 
112
 
112 
 
112 
 
114 
 
110
 
110
 
110
 
110
 
72 
 
71 
 
73 
 
74 
 
71 
 
74 
 
71 
 
71 
 
71 
 
99 
 
99 
 
98 
 
97 
 
98 
 
98 
 
99 
 
99 
 
99 
 5 
 
Sekar 
 
36002 
 
34 
 
17 
 
12 
 
5.9 
 
4.9 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
69 
 
70 
 
69 
 
69 
 
70 
 
71 
 
70 
 
70 
 
71 
 
120 
 
120 
 
120 
 
120 
 
120 
 
120 
 
120 
 
120 
 
120 
 
83 
 
81 
 
82 
 
81 
 
81 
 
81 
 
81 
 
82 
 
83 
 
99 
 
99 
 
98 
 
99 
 
98 
 
98 
 
99 
 
98 
 
99 
 6 
 
Vijendran 
 
37773 
 
37 
 
19 
 
17 
 
5.3 
 
4.8 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
84 
 
85 
 
84 
 
83 
 
84 
 
84 
 
85 
 
86 
 
84 
 
108
 
108
 
110 
 
110 
 
108 
 
108
 
110
 
108
 
106
 
68 
 
69 
 
70 
 
71 
 
71 
 
71 
 
69 
 
70 
 
71 
 
98 
 
99 
 
99 
 
99 
 
99 
 
99 
 
99 
 
98 
 
99 
 7 
 
Nethravathi 
 
37786 
 
24 
 
22 
 
18 
 
6.6 
 
5.4 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
75 
 
76 
 
75 
 
75 
 
76 
 
75 
 
74 
 
75 
 
76 
 
126 
 
124 
 
124 
 
126 
 
126 
 
126 
 
126 
 
124 
 
124 
 
84 
 
85 
 
83 
 
83 
 
84 
 
85 
 
83 
 
83 
 
83 
 
99 
 
99 
 
99 
 
99 
 
99 
 
99 
 
99 
 
99 
 
99 
 8 
 
Uma 
 
37812 
 
22 
 
16 
 
12 
 
5.8 
 
5.0 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
76 
 
75 
 
74 
 
75 
 
75 
 
76 
 
77 
 
77 
 
76 
 
134
 
134
 
134 
 
134 
 
132 
 
132
 
132
 
134
 
134
 
88 
 
87 
 
87 
 
88 
 
85 
 
90 
 
91 
 
83 
 
84 
 
98 
 
99 
 
99 
 
98 
 
98 
 
99 
 
99 
 
98 
 
98 
 9 
 
Revathi 
 
37839 
 
38 
 
19 
 
14 
 
6.5 
 
5.3 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
80 
 
82 
 
80 
 
79 
 
80 
 
79 
 
81 
 
80 
 
82 
 
102
 
102
 
102 
 
102 
 
104 
 
102
 
104
 
104
 
102
 
69 
 
70 
 
71 
 
71 
 
71 
 
71 
 
71 
 
71 
 
70 
 
98 
 
99 
 
98 
 
98 
 
98 
 
99 
 
99 
 
98 
 
99 
 10 
 
Manjunath 
 
37861 
 
24 
 
17 
 
13 
 
5.2 
 
4.8 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
68 
 
69 
 
67 
 
66 
 
67 
 
67 
 
68 
 
69 
 
68 
 
106
 
106
 
108 
 
108 
 
108 
 
108
 
108
 
108
 
108
 
70 
 
70 
 
70 
 
70 
 
70 
 
72 
 
71 
 
70 
 
69 
 
98 
 
99 
 
99 
 
99 
 
98 
 
98 
 
98 
 
98 
 
99 
 11 
 
Chestasamy 
 
38111 
 
38 
 
18 
 
15 
 
6.3 
 
5.3 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
71 
 
70 
 
70 
 
69 
 
70 
 
70 
 
71 
 
72 
 
71 
 
120
 
120
 
120 
 
118 
 
118 
 
120
 
120
 
118
 
120
 
85 
 
84 
 
84 
 
85 
 
82 
 
80 
 
81 
 
82 
 
83 
 
98 
 
99 
 
99 
 
99 
 
98 
 
98 
 
99 
 
99 
 
98 
 12 
 
Yashodha 
 
38162 
 
35 
 
20 
 
18 
 
6.0 
 
5.4 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
79 
 
80 
 
81 
 
79 
 
79 
 
80 
 
80 
 
79 
 
81 
 
122
 
122
 
122 
 
122 
 
120 
 
120
 
120
 
122
 
122
 
85 
 
84 
 
73 
 
83 
 
82 
 
81 
 
81 
 
80 
 
79 
 
99 
 
99 
 
99 
 
99 
 
98 
 
98 
 
98 
 
99 
 
99 
 13 
 
Suvarna 
 
38200 
 
29 
 
23 
 
19 
 
4.8 
 
3.8 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
79 
 
80 
 
79 
 
81 
 
81 
 
80 
 
82 
 
80 
 
80 
 
108
 
110
 
110 
 
108 
 
108 
 
106
 
108
 
110
 
108
 
69 
 
70 
 
71 
 
72 
 
73 
 
70 
 
71 
 
72 
 
70 
 
99 
 
99 
 
99 
 
98 
 
98 
 
99 
 
99 
 
99 
 
99 
 14 
 
Lalitha 
 
38281 
 
21 
 
20 
 
18 
 
6.1 
 
5.2 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
72 
 
72 
 
73 
 
72 
 
75 
 
73 
 
74 
 
72 
 
72 
 
130 
 
130 
 
130 
 
130 
 
130 
 
128 
 
128 
 
128 
 
128 
 
81 
 
80 
 
80 
 
80 
 
80 
 
80 
 
79 
 
78 
 
80 
 
99 
 
99 
 
99 
 
98 
 
99 
 
99 
 
98 
 
99 
 
99 
 15 
 
Suresh 
 
38331 
 
18 
 
21 
 
19 
 
5.7 
 
4.9 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
81 
 
82 
 
82 
 
81 
 
83 
 
82 
 
82 
 
81 
 
83 
 
128
 
126
 
126 
 
128 
 
126 
 
124
 
126
 
126
 
126
 
82 
 
81 
 
80 
 
80 
 
78 
 
79 
 
80 
 
81 
 
80 
 
99 
 
99 
 
99 
 
98 
 
98 
 
98 
 
98 
 
99 
 
99 
 16 
 
Raja 
 
38333 
 
45 
 
19 
 
13 
 
4.6 
 
3.9 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
69 
 
70 
 
59 
 
69 
 
71 
 
70 
 
69 
 
70 
 
71 
 
106 
 
106 
 
106 
 
106 
 
104 
 
104 
 
104 
 
106 
 
106 
 
66 
 
55 
 
66 
 
66 
 
68 
 
67 
 
66 
 
65 
 
66 
 
99 
 
99 
 
99 
 
98 
 
99 
 
99 
 
98 
 
98 
 
98 
 17 
 
Swamy 
 
38413 
 
28 
 
18 
 
15 
 
6.6 
 
5.2 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
73 
 
73 
 
73 
 
74 
 
75 
 
73 
 
72 
 
83 
 
71 
 
130
 
128
 
128 
 
128 
 
130 
 
130
 
130
 
130
 
128
 
76 
 
74 
 
75 
 
75 
 
75 
 
73 
 
72 
 
72 
 
72 
 
99 
 
99 
 
99 
 
98 
 
99 
 
99 
 
98 
 
99 
 
99 
 18 
 
Adaikalam 
 
38469 
 
47 
 
20 
 
13 
 
5.7 
 
5.4 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
85 
 
84 
 
84 
 
83 
 
84 
 
85 
 
86 
 
82 
 
83 
 
102
 
102
 
102 
 
102 
 
104 
 
102
 
102
 
100
 
102
 
74 
 
75 
 
74 
 
74 
 
74 
 
74 
 
76 
 
72 
 
74 
 
99 
 
98 
 
99 
 
98 
 
99 
 
99 
 
98 
 
99 
 
99 
 19 
 
Surya 
 
505632
 
16 
 
21 
 
17 
 
6.2 
 
5.6 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
68 
 
65 
 
70 
 
70 
 
70 
 
71 
 
68 
 
69 
 
70 
 
116
 
118
 
118 
 
118 
 
118 
 
115
 
116
 
116
 
116
 
72 
 
70 
 
71 
 
70 
 
71 
 
72 
 
72 
 
73 
 
72 
 
99 
 
98 
 
99 
 
97 
 
99 
 
98 
 
98 
 
99 
 
99 
 20 
 
Ammulu 
 
506181
 
51 
 
16 
 
12 
 
6.4 
 
5.8 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
72 
 
73 
 
74 
 
72 
 
71 
 
72 
 
72 
 
73 
 
72 
 
122
 
122
 
120 
 
120 
 
120 
 
122
 
120
 
120
 
120
 
80 
 
79 
 
79 
 
80 
 
81 
 
82 
 
83 
 
81 
 
82 
 
99 
 
98 
 
99 
 
99 
 
99 
 
98 
 
98 
 
99 
 
99 
 21 
 
Jayanth 
 
509372
 
54 
 
20 
 
15 
 
6.1 
 
5.2 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
82 
 
80 
 
79 
 
80 
 
81 
 
82 
 
82 
 
81 
 
80 
 
114
 
113
 
116 
 
114 
 
114 
 
112
 
114
 
114
 
114
 
64 
 
66 
 
66 
 
66 
 
67 
 
65 
 
66 
 
65 
 
66 
 
99 
 
98 
 
99 
 
98 
 
99 
 
98 
 
98 
 
99 
 
98 
 22 
 
Venkatesh 
 
509929
 
31 
 
21 
 
18 
 
4.7 
 
4.9 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
78 
 
77 
 
78 
 
79 
 
80 
 
81 
 
80 
 
78 
 
79 
 
126
 
126
 
126 
 
126 
 
128 
 
126
 
124
 
126
 
126
 
86 
 
84 
 
85 
 
84 
 
85 
 
86 
 
86 
 
87 
 
86 
 
98 
 
99 
 
99 
 
99 
 
98 
 
98 
 
98 
 
99 
 
99 
 23 
 
Gomathi 
 
516283 
 
38 
 
19 
 
16 
 
6.5 
 
5.8 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
64 
 
65 
 
64 
 
66 
 
65 
 
65 
 
64 
 
66 
 
86 
 
134 
 
132 
 
132 
 
134 
 
130 
 
132 
 
132 
 
132 
 
132 
 
88 
 
86 
 
85 
 
86 
 
86 
 
89 
 
89 
 
89 
 
87 
 
97 
 
99 
 
99 
 
98 
 
98 
 
98 
 
98 
 
99 
 
99 
 24 
 
Priya 
 
514926
 
22 
 
17 
 
12 
 
6.1 
 
5.6 
 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
62 
 
63 
 
62 
 
62 
 
64 
 
63 
 
62 
 
63 
 
62 
 
128
 
130
 
128 
 
128 
 
128 
 
130
 
130
 
130
 
130
 
88 
 
85 
 
85 
 
86 
 
87 
 
87 
 
86 
 
87 
 
87 
 
97 
 
99 
 
98 
 
98 
 
98 
 
98 
 
98 
 
99 
 
98 
 
 
25 Ganesh raj    521687 37 18 15 4.9 4.8 3 1     1     1     1     1     1 1 1     1 88 87 88 88 89 89 87 88 89 108 108 110 108 108  108110110 110 68 69 70 71 71 71 71 71 71 98 99 98 98 98 98 99 99 99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 Parvathi  50105 38 18 16 5.3 4.8 3      1      1      1      1      1      1      1      1      1     89 90 91 90 89 88 89 88 90 134 130 132 130 132 130 132 132 130 86 86 86 84 84 84 84 86 86 99 98 99 98 99 99 99 99  98 
 
27 Mahmood         50105  51 17 13 5.7 5.0 2      1      1      1      1      1      1      1      1      1     67 66 66 65 67 66 65 67 67 126 126 126 124 120 124 122 124 124 80 82 82 82 80 80 80 80 80 99 99 99 98 99 99 99 99  99 
 
28 Nagraj 
 
29 Devi 
 
30 Shankar 
 
31 Deepa 
 
32 Pappathi 
 
33 Iqbal 
 
34 Kumar 
 
35 Jayan 
45312  22 19 16 6.2 5.7 2      1      1      1      1      1      1      1      1 
 
45389 28 21 18 6.0 5.4 2      1      1      1      1      1      1      1      1 
 
45400 33 19 16 5.3 4.9 3      1      1      1      1      1      1      1      1 
 
45562 20 17 13 5.9 4.8 2      1      1      1      1      1      1      1      1 
 
45712 28 20 17 6.1 5.3 2      1      1      1      1      1      1      1      1 
 
45846 28 20 14 6.2 5.5 2      1      1      1      1      1      1      1      1 
 
46871 30 18 15 5.9 4.7 2      1      1      1      1      1      1      1      1 
 
54005 48 19 13 5.9 4.9 2      1      1      1      1      1      1      1      1 
1     79 80 81 79 80 80 81 74 79 114 114 124 124 116 112 110 110 110 72 74 74 70 70 70 74 74 74 99 99 99 98 98 98 99 99  98 
 
1     83 83 82 83 81 83 82 82 82 122 120 120 122 120 122 120 122 120 82 84 84 84 84 84 84 84 84 99 99 99 98 99 99 99 98  99 
 
1     78 77 77 78 78 79 77 77 78 118 116 118 120 116 118 120 116 120 70 72 70 72 70 72 70 72 70 99 99 99 98 99 99 99 98  98 
 
1     74 75 75 74 75 74 76 75 79 116 118 118 118 118 116 120 120 118 68 70 70 70 68 68 68 68 70 99 98 99 98 99 99 99 99  99 
 
1     86 85 86 87 88 88 86 85 86 102 104 104 104 104 102 104 104 104 66 68 66 66 66 66 66 68 66 99 98 98 98 98 98 98 98  99 
 
1     72 73 73 72 71 72 73 70 70 130 132 130 132 130 130 130 128 130 88 86 86 88 88 88 88 88 88 99 98 98 99 99 99 99 99  99 
 
1     66 67 67 68 69 68 67 66 66 106 106 106 104 108 108 104 106 106 70 68 68 68 68 68 72 72 72 99 98 98 99 99 99 99 99  99 
 
1     79 80 80 81 81 80 79 78 77 128 130 128 130 128 128 130 130 128 84 82 82 82 82 82 82 82 82 99 99 98 99 99 99 99 99  99 
 
36 Jackson 52105  17 21 16 5.8 4.9 3      1      1      1      1      1      1      1      1      1     87 86 85 87 88 89 86 84 85 130 128 126 126 126 126 126 126 126 86 88 88 88 86 86 88 88 88 99 99 98 99 99 99 99 99  98 
 
37 Anitha 
 
38 Gunamoorthy 
 
39 Asif Khan 
 
40 Raghavendra 
 
41 Veeramoorthy 
 
42 Hashim 
 
43 Pattammal 
 
44 Pallavi 
52205 20 20 14 5.2 4.7 3      1      1      1      1      1      1      1      1 
 
52205 42 23 19 5.9 4.9 2      1      1      1      1      1      1      1      1 
 
55205  46 20 18 5.6 5.0 2      1      1      1      1      1      1      1      1 
 
50105 40 18 14 6.2 5.6 2      1      1      1      1      1      1      1      1 
 
62105 50 17 14 6.0 5.2 2      1      1      1      1      1      1      1      1 
 
61105 19 19 15 6.1 5.6 2      1      1      1      1      1      1      1      1 
 
 61105 31 16 12 6.3 5.7 2      1      1      1      1      1      1      1      1 
 
48136 26 21 17 5.9 4.8 2      1      1      1      1      1      1      1      1 
1     73 74 70 71 72 73 73 72 70 108 106 108 110 110 110 110 110 110 72 74 74 74 72 74 74 74 74 98 98 98 99 99 99 99 98  99 
 
1     85 83 82 80 81 83 81 82 80 102 100 100 100 104 104 104 104 104 68 70 70 70 68 68 68 68 68 98 98 98 99 99 99 99 98  99 
 
1     70 71 71 71 70 69 72 72 70 122 120 124 124 124 124 124 124 124 88 86 86 88 88 88 88 86 86 98 98 98 98 99 99 99 98  99 
 
1     80 79 79 80 78 79 81 80 82 120 118 118 118 122 122 122 122 122 70 68 68 68 68 70 70 70 70 98 98 98 98 98 99 99 98  98 
 
1     68 67 68 67 68 70 71 69 70 106 104 104 108 108 108 108 108 108 70 70 70 70 70 70 70 70 70 98 98 98 98 98 98 98 99  99 
 
1     77 77 78 78 75 76 75 76 75 102 104 104 102 102 100 100 100 100 68 68 68 68 68 68 68 68 70 99 99 98 98 98 99 99 98  99 
 
1     86 85 84 85 83 84 83 82 84 108 106 108 106 108 106 108 106 108 74 76 74 74 74 74 74 74 74 99 99 99 98 98 99 99 98  99 
 
1     82 81 80 80 79 81 80 80 79 130 132 130 132 130 132 132 128 128 88 86 88 86 88 86 88 86 88 98 99 99 99 98 99 98 98  99 
 
45 Shanmugapriya 48318 33 19 14 5.8 4.8 2      1      1      1      1      1      1      1      1      1     72 73 73 73 72 72 71 72 70 112 110 110 110 110 110 110 110 110 74 74 74 74 74 74 74 74 74 99 98 99 99 98 99 98 99  99 
 
46 Ganesh 
 
47 Rehmattulla 
 
48 Janardhana 
 
49 Selvaraj 
 
50 Shahjahan 
49112 36 19 15 5.9 5.4 2      1      1      1      1      1      1      1      1 
 
49116 28 17 13 5.1 5.8 3      1      1      1      1      1      1      1      1 
 
49378 26 18 16 5.9 4.9 2      1      1      1      1      1      1      1      1 
 
49431 48 19 15 5.8 4.7 2      1      1      1      1      1      1      1      1 
 
611005 43 20 17 6.4 5.6 2      1      1      1      1      1      1      1      
1     74 75 75 76 76 76 74 73 74 112 114 114 114 114 114 114 114 114 72 74 72 72 72 74 74 74 74 99 98 99 98 99 99 98 99  99 
 
1     81 80 79 79 80 79 82 82 82 136 138 138 138 134 134 134 134 134 84 86 86 86 82 72 72 72 72 98 98 99 98 99 99 98 99  99 
 
1     69 69 70 69 71 71 71 69 70 120 122 122 122 122 122 122 122 122 72 72 72 74 74 72 72 72 72 98 99 99 98 98 99 98 99  99 
 
1     79 80 80 80 79 79 81 80 81 128 126 126 126 126 126 126 126 126 78 78 78 80 80 80 76 76 76 99 99 98 98 99 98 98 99  98 
 
1     77 77 76 75 78 77 76 77 79 108 106 110 110 110 110 106 106 106 68 70 68 72 68 72 72 72 72 99 99 98 98 99 99 98 98  98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl. Patient Name      IP.       Age     Onset of Block Duration of block Sedation score 
No. No.     (yrs)                                                                          
MASTER CHART 
 
BUPIVACAINE - MIDAZOLAM GROUP 
 
Pulse Rate Systolic BP Diastolic BP O2 Saturation 
 
Sensory Motor Sensory Motor No. of      0        5       15      30      60      2       6      12     24      0        5       15      30      60      2       6      12     24      0        5       15      30      60       2       6      12     24       0        5       15      30      60      2       6      12     24      0        5       15      30      60      2       6      12     24 
(min)       (min)       (min)       (min)     RA in min min min min min hrs hrs hrs hrs min min min min min hrs hrs hrs hrs min min min min min hrs hrs hrs hrs min min min min min hrs hrs hrs hrs min min min min min hrs hrs hrs hrs 
24 
hours 
post-
op 
 
1       Anish 
 
2       Sowmya 
 
3       Mariammal 
 
4       Gowri 
 
5       Sharadha 
 
6       Ravi 
 
7       Bhaskaran 
 
8       Raghavan 
26649     26 12 
 
26200     28 11 
 
26788     47 10 
 
28905     42 11 
 
27476     38 13 
 
27975     29 11 
 
27945     50 10 
 
27996     52 14 
10 13.1 5.7 
 
9 11.3 5 
 
8 13.3 4.6 
 
9 14.3 5.8 
 
11 13.8 5.5 
 
9 15.6 5.8 
 
8 15.2 5.8 
 
12 14.8 4.2 
1 1        1        1        1        1       1       1       1 
 
2 1        1        1        1        2       1       1       1 
 
1 1        1        2        2        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        1        1        2       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
1      77      74      72      75      77     76     75     76     77 110 110 112 112 110 112 110 112 112 70      72      72      72      72     68     68     72     72     98      99      99      98      99     99     99     98     99 
 
1      82      81      80      84      81     82     83     83     84 122 120 118 118 120 120 122 120 122 78      78      78      78      78     78     78     78     78     99      99      98      99      99     98     99     99     99 
 
1      68      69      71      73      70     69     68     67     67 136 136 134 136 138 136 136 136 138 76      78      78      78      76     76     76     76     76     99      99      98      98      99     98     99     99     99 
 
1      88      86      85      84      87     88     88     87     88 102 102 104 102 102 104 102 104 104 68      68      68      68      68     68     68     68     68     98      98      98      99      99     98     99     99     98 
 
1      82      81      82      81      81     83     81     82     82 104 104 102 102 104 104 104 104 106 70      68      70      70      70     68     68     68     70     99      98      99      98      99     98     98     99     99 
 
1      76      75      76      75      77     78     75     77     76 104 102 102 104 106 104 104 106 106 70      72      72      72      70     70     70     70     70     98      99      98      99      99     99     99     99     98 
 
1      73      71      72      74      75     74     73     71     73 134 132 134 134 134 132 134 136 136 86      88      88      88      88     88     88     84     84     99      98      99      98      99     99     98     99     99 
 
1      90      90      85      88      87     86     88     87     88 128 128 126 126 126 128 130 130 130 84      82      82      86      86     86     84     84     84     98      98      99      98      98     99     99     98     98 
 
9       Lakshmammal 27475     46 12 10 14.7 5.3 1 1        1        2        2        2       1       1       1       1      88      86      87      90      88     89     89     86     89 126 128 126 124 124 126 128 126 128 82      84      84      84      84     84     84     84     84     99      99      98      99      99     98     98     99     98 
 
10     Bhaskar 27556     22 10 9 11.4 5.2 2 1        1        2        2        1       1       1       1       1      76      76      74      78      79     74     75     74     78 116 116 118 118 118 118 116 116 116 78      76      76      76      76     76     76     76     76     99      98      98      99      98     99     99     98     98 
 
11     Sachidananda 28747     24 11 10 15 4.4 1 1        1        1        1        1       1       1       1       1      76      76      75      77      78     73     76     75     77 112 114 114 114 114 112 112 110 112 72      72      74      72      74     74     72     72     72     99      99      98      99      98     99     98     99     98 
 
12     Shivamurthy 
 
13     Satyaseelan 
 
14     Lalitha 
 
15     Renuka 
 
16     Firoz knan 
 
17     Mariammal 
 
18     Roopa 
 
19     Arun 
 
20     Devi 
 
21     Reshmi 
 
22     Prakash 
 
23     Balaji 
 
24     Bhagya 
28582     26 9 
 
27579     17 14 
 
29791     19 13 
 
29429     19 8 
 
27426     27 11 
 
27976     37 10 
 
28000     33 9 
 
28163     25 13 
 
28421     29 11 
 
29111     16 12 
 
29262     17 10 
 
29420     53 13 
 
29727     32 9 
8 15.1 5.2 
 
13 15.7 5.5 
 
12 14.4 5.3 
 
7 13.6 5.6 
 
9 14.3 5.0 
 
9 13.6 5.9 
 
8 13.4 5.1 
 
10 14.6 5.8 
 
9 13.8 4.7 
 
11 12.1 5.6 
 
9 12.5 5.2 
 
10 14.2 4.8 
 
8 14.3 5.0 
1 1        1        1        1        2       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        2        2        2       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
1 1        1        2        2        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
 
2 1        1        1        1        2       1       1       1 
 
2 1        1        1        1        1       1       1       1 
 
1 1        1        2        2        1       1       1       1 
 
1 1        1        1        1        1       1       1       1 
1      74      74      75      73      74     71     74     73     75 134 132 134 134 134 136 136 136 136 88      86      88      88      86     86     86     88     88     99      98      98      98      98     99     98     99     98 
 
1      76      84      87      85      87     86     86     88     87 132 132 134 136 136 134 134 136 136 88      86      86      88      88     88     88     88     86     99      99      98      98      98     99     99     98     99 
 
1      86      85      84      87      88     87     86     84     88 138 136 138 138 138 138 138 138 136 86      86      86      86      84     84     86     84     86     99      98      99      99      98     98     99     99     98 
 
1      84      82      84      85      81     83     84     80     83 110 110 112 108 112 112 112 110 112 82      84      82      84      82     84     82     88     84     99      99      98      99      99     98     98     98     99 
 
1      82      80      81      83      84     82     83     84     83 102 104 102 102 104 102 102 104 104 68      70      70      70      70     68     68     68     68     99      98      99      99      98     99     98     99     98 
 
1      82      80      81      84      83     83     82     84     83 106 104 108 106 106 104 108 108 108 70      68      68      68      72     72     72     72     72     99      98      99      98      99     99     99     98     99 
 
1      70      71      70      71      72     72     72     71     72 112 110 112 112 112 114 114 114 112 72      72      72      72      72     72     72     72     72     99      99      99      98      99     98     99     98     98 
 
1      68      70      71      66      67     71     70     70     69 126 128 128 128 126 126 126 126 128 76      78      78      76      78     76     78     76     78     98      98      98      98      99     99     99     98     99 
 
1      68      66      66      67      68     70     70     69     69 114 116 116 116 114 114 114 114 114 74      74      76      72      72     76     76     72     72     99      98      98      99      99     98     99     99     98 
 
1      68      66      67      68      69     70     69     70     67 128 126 128 130 113 128 126 128 128 84      82      86      86      82     82     86     86     86     99      98      99      98      98     99     98     99     99 
 
1      70      68      71      70      72     71     69     70     72 112 110 110 112 112 112 114 114 114 80      80      80      80      80     80     80     80     80     99      98      99      98      99     99     98     99     98 
 
1      70      71      72      69      68     70     71     70     71 118 116 116 116 118 118 120 120 120 84      86      86      84      84     84     84     84     84     98      98      99      98      99     99     99     98     99 
 
1      84      84      83      82      81     84     81     83     83 108 108 110 110 110 110 110 106 110 82      88      80      80      80     80     80     80     80     99      99      98      99      99     99     98     99     98 
 
25     Ateeq Ahmed 29999     30 12 11 12.7 5.4 2 1        1        1        1        2       1       1       1       1      86      86      84      85      84     86     88     87     88 110 110 110 112 112 112 110 112 112 72      74      70      70      74     74     74     74     74     98      98      99      99      98     99     98     99     99 
 
 
 
 
 
 
 
 
 
 
26 Veerammal 30186  34 12 11 15.2 5.4 1 1 1 1 2 2 1 1 1 1 76 76 74 74 76 76 76 76 76 108 108 108 108 110 110 110 110 110 72 70 70 70 70 70 70 70 70  98 99 99 98 98 99 99 98 99 
 
27 Gangadharal 31126  26     9      8     13.6 5.0 1 1 1 1 1 1 1 1 1 1 82 82 84 84 82 82 86 86 84 120 130 130 130 126 126 126 126 126 81 83 83 83 83 83 83 83 81  99 98 99 99 99 99 99 98 99 
 
28 Mohan 31127  18 13 10 13.0 4.8 2 1 1 1 1 1 1 1 1 1 88 90 90 86 86 86 86 86 85 134 136 136 132 132 132 136 136 136 86 86 86 86 86 86 86 86 86  99 99 99 99 98 99 99 99 98 
 
29 Radhika 51105  16 10     9     14.2 5.6 1 1 1 2 2 1 1 1 1 1 90 90 90 88 89 89 89 88 88 126 124 124 124 124 128 128 128 128 84 82 84 82 82 84 84 84 84  99 98 98 99 98 98 99 99 99 
 
30 Pakkirisamy 52205  28 12 11 14.8 4.7 1 1 1 1 1 1 1 1 1 1 72 70 70 70 74 74 70 70 70 114 112 116 116 112 112 112 116 116 68 70 70 70 69 69 69 69 70  98 99 99 98 98 99 98 99 98 
 
31 Martha 59505  46 11     9     13.8 5.2 1 1 1 1 2 2 1 1 1 1 76 78 78 78 76 76 76 78 78 122 124 124 124 120 120 120 120 120 82 82 82 82 80 80 80 80 80  98 99 99 98 99 99 98 98 99 
 
32 Rudresh 52505  48 13 10 15.7 5.8 1 1 1 1 1 1 1 1 1 1 76 77 77 77 75 75 75 78 78 116 118 118 118 118 118 114 114 114 70 70 70 70 72 72 72 68 68  98 99 99 99 99 98 98 99 99 
 
33 Ashokan 51205  34     9      8     14.6 5.1 1 1 1 1 1 1 1 1 1 1 74 76 75 75 75 75 75 88 75 102 100 100 100 100 100 100 104 104 68 70 70 70 70 70 70 66 68  98 98 98 99 99 99 99 98 99 
 
34 Raman 
 
35 Vyshali 
 
36 Madanan 
52205  52 10     9 
 
55005  20 11     9 
 
42267 20 11     9 
14.2 5.9 1 1 1 2 2 1 1 1 1 1 86 84 84 88 88 88 88 88 88 113 128 128 132 132 132 128 128 128 82 84 84 84 80 80 80 82 82  98 98 98 98 98 99 99 98 99 
 
11.9 5.0 2 1 1 1 1 1 1 1 1 1 84 82 82 82 82 82 82 82 82 106 104 104 106 106 106 106 106 104 70 72 72 70 70 70 71 71 71  99 99 99 98 98 99 99 99 99 
 
15.8 5.3 1 1 1 1 2 2 1 1 1 1 82 84 84 84 83 83 84 83 83 128 126 126 126 126 128 128 128 128 82 82 82 82 82 82 82 82 82  99 98 99 99 99 98 98 99 99 
 
37 Vairakannu 
 
38 Shivakumar 
42411  30 13 10 14.3 5.6 1 1 1 1 1 1 1 1 1 1 82 80 80 80 79 83 83 83 82 113 130 130 130 130 130 130 130 130 86 86 86 84 84 84 84 84 84  99 99 98 99 98 99 99 99 99 
 
42299  32 14 12 13.7 5.2 1 1 1 1 1 1 1 1 1 1 70 72 68 68 68 68 68 69 70 108 110 110 110 106 106 106 106 106 68 70 70 70 70 68 68 68 68  99 98 98 99 98 99 99 99 99 
 
39 Saraswathi 
 
40 Meera 
 
41 Muthusamy 
42783 38 10     9 
 
45626 18 11     9 
 
42927 53 10     9 
14.1 5.5 1 1 1 1 2 2 1 1 1 1 68 70 70 66 66 66 68 68 68 122 122 122 124 124 124 124 124 124 86 84 84 84 88 88 88 86 88  99 99 98 98 98 99 99 99 99 
 
12.9 4.4 2 1 1 1 1 1 1 1 1 1 66 70 65 65 65 65 67 67 67 120 118 118 118 118 118 118 118 118 76 78 78 78 78 78 78 74 74  99 99 98 98 98 99 99 98 99 
 
13.5 5.3 1 1 1 2 2 1 1 1 1 1 70 72 72 72 72 69 69 69 70 106 104 104 104 104 104 104 104 104 72 70 70 70 70 74 74 74 74  98 98 99 98 98 99 99 99 99 
 
42 Anjalai 
 
43 Parameshwaran 
43001  50 13 11 12.1 5.2 2 1 1 1 1 1 1 1 1 1 86 84 84 84 84 84 88 88 87 102 104 104 100 100 100 100 100 100 70 72 72 72 72 72 72 72 72  99 99 99 99 98 99 99 99 99 
 
43018  45 14 12 14.4 5.5 1 1 1 1 2 2 1 1 1 1 86 80 80 80 80 79 80 81 80 134 134 134 136 136 136 136 136 136 88 90 90 90 90 86 86 86 86  98 98 99 98 99 98 99 99 99 
 
44 Abdul Khadir 
 
45 Kamal 
61205  40 10     8 
 
62205  18 11     9 
13.7 4.2 1 1 1 1 1 1 1 1 1 1 75 74 74 74 76 76 76 77 76 126 128 128 128 128 126 126 126 126 76 74 74 74 78 78 76 76 76  99 99 99 98 98 99 98 99 99 
 
15.9 5.8 1 1 1 1 1 1 1 1 1 1 69 67 67 67 69 69 72 71 70 108 110 110 110 110 110 110 110 110 68 70 70 70 66 66 66 66 70  98 99 99 98 98 99 99 99 99 
 
46 Maruthambal 62005   54 13 11 10.8 5.5 2 1 1 2 2 1 1 1 1 1 71 73 73 68 68 68 70 70 70 120 118 118 120 120 120 120 118 118 70 72 72 72 72 68 68 68 68 98 98 98 99 99 98 99 99 99 
 
47 Saranya 
 
48 Seetha 
 
49 Krishna 
61205  23 11     9 
 
44126 41 10     8 
 
43921 52 11     9 
11.8 4.6 2 1 1 1 1 1 1 1 1 1 81 80 80 80 80 81 81 82 82 112 114 114 114 110 110 110 110 110 72 70 72 70 72 70 72 70 72  98 99 99 99 99 98 98 99 99 
 
12.4 5.8 2 1 1 1 2 2 1 1 1 1 89 88 88 88 88 88 88 88 90 104 104 104 106 106 106 104 104 104 68 70 66 70 66 66 70 70 66  98 99 99 99 99 98 99 99 99 
 
13.1 5.7 2 1 1 1 1 1 1 1 1 1 90 90 90 87 89 89 89 90 90 122 120 122 120 122 120 120 120 120 74 72 76 72 72 76 76 76 76  99 98 98 99 99 99 99 99 99 
 
50 Moorthy 44012  44 12 10 14.5 5.0 1 1 1 1 1 1 1 1 1 1 70 72 72 72 69 69 69 70 70 110 110 112 112 112 112 112 110 110 76 78 78 74 74 74 74 74 74  99 98 98 99 99 98 99 99 99 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE III 
  
KEY TO MASTER CHART 
 
 
  
Sl. No. 
  
IP No. 
  
RA 
  
Yrs 
  
Min 
  
Hrs 
  
Post-Op 
  
PR 
  
SBP 
  
DBP 
  
SpO2 
 
- Serial Number 
  
- In-patient number 
  
- Rescue analgesics 
  
- Years 
  
- Minutes 
  
- Hours 
  
- Post-operative 
  
- Pulse rate 
  
- Systolic blood pressure 
  
- Diastolic blood pressure 
  
- Oxygen saturation 
 
 
 
 
 
 
 
 
 
 
 
 
                         
 
 
 
 
                                         ANNEXURE IV 
 
 
 
List of Statistical formulae used 
 
 
Σ x          Sum of all the values  
n            Number of values 
 
 
 
 
2) SD = 
Σ (x - x)2 
 
(n -1) 
 
 
 
 
3) t = Difference of means  
SE of mean 
 
1) Mean = = 
  
 
 
 
 
 
 
CONSENT FORM 
 
 
 
I __________________________________________  hereby give consent to 
participate in the study conducted by Dr.ROSHIN ANN JAMES, Post 
Graduate in Anaesthesia, Department of Anesthesiology,Thanjavur Medical 
College and hospital,Thanjavur and to use my personal clinical data and result 
of investigation for the purpose of analysis and to study the nature of disease. I 
also give consent for further investigations 
 
 
Place : 
Date :       Signature of Participant 
 
 
 
 
 
